syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.52803179	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.16549693642173
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	1.3889047	90.89501338188782
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.44034283475214
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	1.0598896	69.36305952116349
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.041378882	68.15165030041686
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	1.030303	67.42680399339073
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	1.001759633	65.55882145619498
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.001759633	65.55882145619498
YOU-HOOVER-FONG SYNDROME; YHFS	1.000843882	65.49889135487163
JOUBERT SYNDROME 1	1.000843882	65.49889135487163
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.44366462428115
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	65.44366462428115
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	62.067596119842506
CENTRALOPATHIC EPILEPSY	0.9484125999999999	62.067596119842506
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	41.811211270676516
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.6096488	39.89765160579545
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.542357882	35.493887335943455
EPILEPSY, JUVENILE ABSENCE	0.5419408	35.46659196141462
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.5411276819999999	35.41337853972266
LANDAU-KLEFFNER SYNDROME	0.534017733	34.94807742187091
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.5303309	34.70679755949318
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.529235782	34.63512902437717
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.519711782	34.011843562495514
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	33.95661683190505
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.684240299738796
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.5147059	33.684240299738796
TRICHOHEPATOENTERIC SYNDROME 1	0.50341297	32.94518957619331
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.77705904273104
COMBINED SAPOSIN DEFICIENCY	0.5	32.72183231214058
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.72183231214058
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.72183231214058
IMMUNODEFICIENCY 36; IMD36	0.5	32.72183231214058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.72183231214058
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.49042353299999997	32.09511321750708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.488691082	31.98173527528508
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.47991090000000003	31.407127989136928
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.47991090000000003	31.407127989136928
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.520889882794915
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	29.34576380770193
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	29.34576380770193
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.030807768731044
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.030807768731044
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.559292709479557
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.64817292184739
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.353044782	23.10454431056045
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	22.89231705055037
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.776941047803724
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.334248751	21.87446316152886
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.334248751	21.87446316152886
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.334248751	21.87446316152886
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.645477807762102
TUBEROUS SCLEROSIS	0.32591575100000003	21.329121104214725
AICARDI SYNDROME; AIC	0.325	21.269191002891375
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.320563882	20.97887518426564
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.281174782	18.401108134013363
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.2803309	18.345881403422894
WHITE-SUTTON SYNDROME; WHSUS	0.27791199200000005	18.18757919951391
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.378550874258973
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.323324143668504
HYPEREKPLEXIA 1; HKPX1	0.25925926	16.96687606217931
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.255620633	16.728750977098453
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.254776751	16.673524246507988
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.254776751	16.673524246507988
FRYNS SYNDROME; FRNS	0.254552111	16.65882298168679
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.25419958200000004	16.635752192040457
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25363636	16.59889288036344
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.2533557	16.580525461449987
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.2533557	16.580525461449987
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.2533557	16.580525461449987
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	16.420846257393638
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.36091615607029
DYSTONIA 6, TORSION	0.25	16.36091615607029
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.36091615607029
HYPERPARATHYROIDISM 2	0.25	16.36091615607029
CHROMOSOME 1P36 DELETION SYNDROME	0.239724613	15.68845717535759
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.234417682	15.341152162809388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.2335738	15.285925432218919
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.231617033	15.157867428923058
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.687397308664632
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.687397308664632
EPILEPSY, IDIOPATHIC GENERALIZED	0.2233137	14.614466888807334
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.219711782	14.378744175211173
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.216465533	14.166297744368261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.215549782	14.106367643044912
FEBRILE CONVULSIONS, FAMILIAL, 9	0.215205	14.083803845468426
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.208532582	13.647136359643408
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.204271733	13.368290786672704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.143959655446697
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.19441408200000002	12.723169980645496
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.1855349	12.142083771699541
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.920130405140327
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.864903674549861
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.174745433	11.435981511876792
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.16842663300000002	11.022456083848885
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.16842663300000002	11.022456083848885
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.16842663300000002	11.022456083848885
WITTEVEEN-KOLK SYNDROME	0.164607973	10.772548979494726
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.156578882	10.247095840852891
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.153904982	10.072106026014026
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1471846	9.632299600258971
SMITH-MAGENIS SYNDROME; SMS	0.144537103	9.45903769449718
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.14054978199999998	9.198092796223827
ACROCRANIOFACIAL DYSOSTOSIS	0.13940197	9.122975772644102
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.138493293	9.063508619804303
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.79723189528668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.133656781	8.746989550524994
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.13199206	8.638044107707994
AGNATHIA-OTOCEPHALY COMPLEX	0.12841297	8.403815342087876
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.12638470300000001	8.27107811677138
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.240388179358494
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.240388179358494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125843882	8.235684808625612
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.229141620149145
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.125	8.180458078035144
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.125	8.180458078035144
WILDERVANCK SYNDROME	0.125	8.180458078035144
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.12060391300000001	7.892762034747982
3MC SYNDROME 2	0.118882212	7.780087611920691
Glycosylphosphatidylinositol biosynthesis defect 18	0.11539603300000001	7.55193928262448
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.111119851	7.272090261944092
3MC SYNDROME 3	0.10970874	7.1797419869124575
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.075029505767024
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.10668159999999999	6.981634851981711
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.10574098200000001	6.920077363050151
MENTAL RETARDATION, X-LINKED 98; MRX98	0.104136233	6.815056707687998
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.10363636000000001	6.782343186721267
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.10335570000000001	6.763975767807816
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.10175963300000002	6.659523294341933
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.10091575100000001	6.604296563751467
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.604296563751467
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.5443664624281155
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.5443664624281155
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.5443664624281155
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.5443664624281155
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.5443664624281155
3MC SYNDROME 1	0.1	6.5443664624281155
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0996504	6.521487357275466
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.09874504200000002	6.462237411958557
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	6.324140808614984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.09633235200000001	6.304342136756199
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.09568585100000002	6.262032742132938
NOONAN SYNDROME 7; NS7	0.09523782100000001	6.2327120170713215
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.09516595200000001	6.228008646338439
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.09266873300000002	6.064581483609056
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.09266873300000002	6.064581483609056
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.08991828199999999	5.884581890799535
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.08973155099999999	5.872361529860579
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.81243142853723
LISSENCEPHALY 2; LIS2	0.08875598200000001	5.808516719406735
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.08611904200000002	5.635945702412384
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0804656	5.265963740191557
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	5.1614698408859665
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.112786298771964
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07776698200000001	5.08935628885051
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.034129558260042
MYOCLONUS AND ATAXIA	0.07692310000000001	5.034129558260042
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.034129558260042
CANAVAN DISEASE	0.07692310000000001	5.034129558260042
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.034129558260042
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.870546574165188
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.072732751	4.759897763645349
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.070917252	4.641084855963632
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.59817004199893
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.069744591	4.564341622761657
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.069069521	4.520162568083744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.06886956000000001	4.507076387461809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.067391572	4.410351436471096
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.064466733	4.218939253875078
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.064211112	4.202210478880155
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.199061853287751
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06335361	4.146092405577504
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.06293129	4.118454237133378
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.061083269999999995	3.9975130360344133
CHROMOSOME 17q12 DELETION SYNDROME	0.058968570000000005	3.8591193184534465
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.056787882	3.716407104331252
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.695692155724064
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.6909887849911818
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.055828989999999995	3.653653697872346
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.635762054400714
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.635762054400714
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.635762054400714
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.635762054400714
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.635762054400714
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.635762054400714
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	3.635762054400714
VELOCARDIOFACIAL SYNDROME	0.05543525999999999	3.6278865637998274
TONNE-KALSCHEUER SYNDROME; TOKAS	0.055077322	3.6044617893715416
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.054480299999999995	3.565390481830224
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.053961962999999995	3.531468609039868
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.053902082	3.5275497769585016
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.053902082	3.5275497769585016
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.053864121	3.525065470005699
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.053369082	3.49266830371376
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.053030299999999995	3.470497168125016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.051600391999999995	3.376918748529439
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.05134860299999999	3.3604407536573566
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.050627633	3.313257834773189
WEAVER SYNDROME	0.050550963	3.308240269006445
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.291661425447176
PEHO-LIKE SYNDROME; PEHOL	0.050290681999999996	3.2912065265343724
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.050124233	3.280313494001325
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.2749764977075513
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04981235999999999	3.259903381983957
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.04959853299999999	3.2459097595083404
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.176504593533358
PELGER-HUET ANOMALY; PHA	0.047536341999999995	3.11095242331313
MAL DE MELEDA	0.04741531	3.1030316456963245
ABLEPHARON-MACROSTOMIA SYNDROME	0.0473393	3.0980572727482327
SHPRINTZEN OMPHALOCELE SYNDROME	0.04711466	3.0833560079270343
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.046891270000000006	3.0687365476866164
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.046819600999999995	3.064046265686658
ACROCALLOSAL SYNDROME; ACLS	0.046743090999999994	3.059039170906254
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.045880682	3.0025999655412927
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.045063951000000005	2.9491500958890393
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.044221832999999995	2.894038807922968
RETT SYNDROME, CONGENITAL VARIANT	0.043977551000000004	2.8780520986412204
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.04391872299999999	2.8742021787387024
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.043816782	2.867530786123239
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.043816782	2.867530786123239
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.8453792836338834
CYCLIC NEUTROPENIA	0.043478300000000004	2.8453792836338834
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.8453792836338834
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.8453792836338834
BAZEX SYNDROME; BZX	0.043478300000000004	2.8453792836338834
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.8453792836338834
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.8453792836338834
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.8453792836338834
LIP, HAMARTOMATOUS	0.043478300000000004	2.8453792836338834
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.8453792836338834
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.043478300000000004	2.8453792836338834
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.8453792836338834
PSEUDOXANTHOMA ELASTICUM; PXE	0.043478300000000004	2.8453792836338834
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.043478300000000004	2.8453792836338834
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.043478300000000004	2.8453792836338834
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.8453792836338834
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.8453792836338834
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.8453792836338834
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.043362682	2.837812818017353
MEHMO SYNDROME; MEHMO	0.043273633000000006	2.831985125126226
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.043074840999999996	2.818975448148235
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.043029421	2.8160029969010005
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.042609152	2.7884990534130183
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.042266732999999994	2.766089899216036
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.042207750999999995	2.762229900989167
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.041975173	2.7470091443581808
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7398371077083414
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0414509	2.7126987979746153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.041262651000000004	2.700379093552759
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.04121332999999999	2.6971513465698247
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.041190782	2.695675722819877
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.041190782	2.695675722819877
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.041190782	2.695675722819877
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.041067063	2.6875790980762253
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.684610377117874
ANGELMAN SYNDROME	0.040960433000000004	2.6806008401173385
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0407925	2.6696106891859888
DYSTONIA 12; DYT12	0.0407925	2.6696106891859888
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.040535	2.6527589455452363
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.040399671	2.643902519855297
NEMALINE MYOPATHY 7; NEM7	0.040203989999999995	2.631096438117953
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.039562259999999995	2.589099275218613
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.039562259999999995	2.589099275218613
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.039394433	2.578116061315714
MACS SYNDROME	0.039336539999999996	2.57432733123962
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.03875523	2.536284274556879
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.038720252	2.533995186055651
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.038609532999999994	2.526749328952115
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.038348951	2.509695887936991
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.038310963	2.507209814005244
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.03810101	2.4934697202863823
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.038095199999999996	2.493089492594915
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.037973352	2.485115312947776
#300867 KABUKI SYNDROME 2; KABUK2	0.03795474299999999	2.483897471792782
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.037878733	2.4789230988446906
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.037576969999999994	2.4591746222766737
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.037430702999999996	2.449602373783074
RAYNAUD-CLAES SYNDROME; MRXSRC	0.037430702999999996	2.449602373783074
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.037301623000000006	2.4411549055533723
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.037138553	2.4304830071630903
MOWAT-WILSON SYNDROME; MOWS	0.036961781000000006	2.4189143996801272
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4167101916119167
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4167101916119167
SUPRABULBAR PARESIS, CONGENITAL	0.036760851000000004	2.4057648041471706
ZIMMERMANN-LABAND SYNDROME 1	0.036538671	2.3912245307409474
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0365199	2.389996087712285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.035974893	2.3543288323863996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.035974893	2.3543288323863996
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.035923569999999995	2.350970067186887
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.03584756	2.345995694238796
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.035622919999999995	2.3312944294175972
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0356138	2.330697583196224
MARSHALL-SMITH SYNDROME; MRSHSS	0.03534226	2.3129270105041466
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.035260511999999994	2.307577121808441
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.034632051	2.2664483308950003
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.034631721	2.266426734485674
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.034559851999999995	2.261723363752792
LATHOSTEROLOSIS	0.034553381	2.2612998777990083
COHEN SYNDROME	0.034546421	2.260844389893223
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.252419237953158
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.034417682	2.252419237953158
BETA-UREIDOPROPIONASE DEFICIENCY	0.034417682	2.252419237953158
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.034417682	2.252419237953158
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.034164	2.235817358223941
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.034164	2.235817358223941
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.034017732999999994	2.2262451097303413
MENTAL RETARDATION, X-LINKED 90	0.034017732999999994	2.2262451097303413
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.034017732999999994	2.2262451097303413
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.033777592	2.210529402663802
OTOONYCHOPERONEAL SYNDROME	0.0336587	2.2027486744892917
EDINBURGH MALFORMATION SYNDROME	0.0336587	2.2027486744892917
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0335738	2.1971925073626903
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.1971925073626903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0335738	2.1971925073626903
FRANK-TER HAAR SYNDROME; FTHS	0.03335697	2.1830023575622075
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.033173851	2.1710183791398734
CORNELIA DE LANGE SYNDROME 1	0.033173851	2.1710183791398734
2q33.1 deletion syndrome	0.033173851	2.1710183791398734
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.033173851	2.1710183791398734
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.033173851	2.1710183791398734
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.033101981999999995	2.166315008406991
SCHAAF-YANG SYNDROME; SHFYNG	0.033063943	2.163825596848348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.032957252	2.156843346825919
HURLER SYNDROME	0.032830442	2.148544435714914
PEHO SYNDROME; PEHO	0.032338532999999996	2.116352108093248
HISTIDINEMIA	0.0322581	2.1110882778165236
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0322581	2.1110882778165236
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.0322581	2.1110882778165236
BREATH-HOLDING SPELLS	0.0322581	2.1110882778165236
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0322581	2.1110882778165236
INFANTILE LIVER FAILURE SYNDROME 1	0.03206263299999999	2.098296201023409
MENTAL RETARDATION, X-LINKED 9	0.03206263299999999	2.098296201023409
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.03206263299999999	2.098296201023409
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.031761133	2.0785649361391885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.031617032999999996	2.0691345040668296
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.031261633000000004	2.0458758256593605
WIEACKER-WOLFF SYNDROME	0.031261633000000004	2.0458758256593605
MENKES DISEASE	0.031218750999999996	2.0430694704329415
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	2.0430694704329415
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.031218750999999996	2.0430694704329415
15q13.3 microdeletion syndrome	0.031218750999999996	2.0430694704329415
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.031206082	2.0422403646458167
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.031190720999999998	2.0412350845135228
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	2.038366099700059
ROSSELLI-GULIENETTI SYNDROME	0.031146881999999997	2.038366099700059
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	2.038366099700059
GALACTOSE EPIMERASE DEFICIENCY	0.031146881999999997	2.038366099700059
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.031146881999999997	2.038366099700059
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.031144552	2.0382136159614848
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.031126041999999996	2.037002253729289
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.031126041999999996	2.037002253729289
JOUBERT SYNDROME 14	0.031118852000000002	2.036531713780641
JOUBERT SYNDROME 3; JBTS3	0.031003659999999995	2.0289931271652404
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.030935761	2.024549567780916
RAINE SYNDROME	0.030921162000000002	2.023594155721067
HYPERPROLINEMIA, TYPE I	0.030831632999999997	2.017735049870919
SHUKLA-VERNON SYNDROME; SHUVER	0.030813603000000002	2.0165551005977433
MOEBIUS SYNDROME; MBS	0.030763440000000003	2.0132722500491957
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.030756333000000004	2.012807141924711
MICROHYDRANENCEPHALY; MHAC	0.030475000000000002	1.9943956794249682
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9849652473526092
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0303309	1.9849652473526092
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.0303309	1.9849652473526092
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.9831393691095913
22q11.2 distal deletion syndrome	0.030302999999999997	1.9831393691095913
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.9831393691095913
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.9831393691095913
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.9831393691095913
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.9831393691095913
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.030302999999999997	1.9831393691095913
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.030302999999999997	1.9831393691095913
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.9831393691095913
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	1.9831393691095913
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.030302999999999997	1.9831393691095913
DWARFISM, LEVI TYPE	0.030302999999999997	1.9831393691095913
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.9831393691095913
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.030302999999999997	1.9831393691095913
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	1.9831393691095913
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030302999999999997	1.9831393691095913
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.9831393691095913
BLAU SYNDROME	0.030302999999999997	1.9831393691095913
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	1.9831393691095913
ALKAPTONURIA	0.030302999999999997	1.9831393691095913
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.030302999999999997	1.9831393691095913
EAR MALFORMATION	0.030302999999999997	1.9831393691095913
OROFACIAL CLEFT 3	0.030302999999999997	1.9831393691095913
NASAL BONES, ABSENCE OF	0.030302999999999997	1.9831393691095913
EAR WAX, WET/DRY	0.030302999999999997	1.9831393691095913
OSTEOMA OF MIDDLE EAR	0.030302999999999997	1.9831393691095913
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.030302999999999997	1.9831393691095913
AREDYLD	0.030302999999999997	1.9831393691095913
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.030302999999999997	1.9831393691095913
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.030302999999999997	1.9831393691095913
DIMPLES, FACIAL	0.030302999999999997	1.9831393691095913
JOUBERT SYNDROME 4	0.030302999999999997	1.9831393691095913
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.030302999999999997	1.9831393691095913
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	1.9831393691095913
OSSIFIED EAR CARTILAGES	0.030302999999999997	1.9831393691095913
HAIRY EARS, Y-LINKED	0.030302999999999997	1.9831393691095913
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.9831393691095913
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.9831393691095913
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	1.9831393691095913
DARWINIAN POINT OF PINNA	0.030302999999999997	1.9831393691095913
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.9831393691095913
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	1.9831393691095913
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.9831393691095913
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.030302999999999997	1.9831393691095913
EAR FOLDING	0.030302999999999997	1.9831393691095913
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.9831393691095913
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.9831393691095913
MUSICAL PERFECT PITCH	0.030302999999999997	1.9831393691095913
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.9831393691095913
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.9831393691095913
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.030302999999999997	1.9831393691095913
CLEFT CHIN	0.030302999999999997	1.9831393691095913
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.9831393691095913
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.9831393691095913
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.030302999999999997	1.9831393691095913
FRYNS MICROPHTHALMIA SYNDROME	0.030302999999999997	1.9831393691095913
EAR WITHOUT HELIX	0.030302999999999997	1.9831393691095913
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03030067	1.9829868853710169
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.030028682	1.9651869939171882
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.029944	1.9596450935094747
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.029915881999999998	1.957804948547569
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.029915881999999998	1.957804948547569
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0298569	1.9539449503206998
HYPEREKPLEXIA 4; HKPX4	0.029585793	1.9362027147354046
SMITH-KINGSMORE SYNDROME; SKS	0.029460980999999997	1.928034560066319
AASE-SMITH SYNDROME I	0.02944274	1.9268408021799073
ROIFMAN-CHITAYAT SYNDROME	0.029364502	1.921720620747033
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.029320892	1.9188666225327684
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.02921426	1.911888233686552
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.029169833	1.9089807679982886
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.029126932999999997	1.9061732347859068
HALLERMANN-STREIFF SYNDROME; HSS	0.02910787	1.9049256822071745
KOOLEN-DE VRIES SYNDROME; KDVS	0.028621633	1.8731045510512578
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.028380710999999996	1.8573377324826466
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.027963182	1.8300131046357353
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.027963182	1.8300131046357353
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.027962589999999996	1.8299743619862776
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.027959832999999996	1.8297939338029083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.027959832999999996	1.8297939338029083
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.027879293	1.824523101054069
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.027836732999999995	1.8217378186876594
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.027777750999999996	1.81787782046079
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.027489681999999998	1.7990255294361384
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.027489681999999998	1.7990255294361384
Xq28 (MECP2) duplication	0.027400633000000004	1.793197836545011
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.027400633000000004	1.793197836545011
SCARF SYNDROME	0.027297589999999997	1.7864543250111307
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.7774291201101255
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.7774291201101255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.7774291201101255
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.7774291201101255
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.027085852	1.7725974143509147
COHEN-GIBSON SYNDROME; COGIS	0.027053462	1.7704776940537343
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.027044081999999997	1.7698638324795581
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.027003092000000003	1.7671812966666094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.026992850999999998	1.7665110880971917
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.026812021	1.7546769102231832
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.026740152000000003	1.7499735394903009
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.026702442	1.7475056588973192
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.026672981999999998	1.7455776885374876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.026672981999999998	1.7455776885374876
BENT BONE DYSPLASIA SYNDROME; BBDS	0.02666431	1.7450101610778659
MENTAL RETARDATION, X-LINKED 104; MRX104	0.026599032999999998	1.7407381949821867
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.026556751000000003	1.7379711059545433
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.026556751000000003	1.7379711059545433
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.026556751000000003	1.7379711059545433
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.026484882000000005	1.7332677352216608
TURNPENNY-FRY SYNDROME; TPFS	0.026484882000000005	1.7332677352216608
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.026484882000000005	1.7332677352216608
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.026484882000000005	1.7332677352216608
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.026421782	1.7291382399838684
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.026403282	1.727927532188319
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.026363659999999997	1.725334523308576
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.7222023895196579
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.7222023895196579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.026174272999999998	1.712940343996377
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.025968240999999996	1.699456854886507
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.0258291	1.6903509579470202
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.025753882	1.685428416381311
WILSON DISEASE	0.025641000000000004	1.6780410046311933
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.025641000000000004	1.6780410046311933
ALLAN-HERNDON-DUDLEY SYNDROME	0.025641000000000004	1.6780410046311933
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.025641000000000004	1.6780410046311933
ORAL SENSIBILITY, DISTURBANCE OF	0.025641000000000004	1.6780410046311933
WILLIAMS-BEUREN SYNDROME; WBS	0.025132259999999997	1.6447471946902361
CATEL-MANZKE SYNDROME; CATMANS	0.024588633	1.609170251621532
INFANTILE SIALIC ACID STORAGE DISEASE	0.024486933	1.6025146309292426
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.024486933	1.6025146309292426
RECOMBINANT CHROMOSOME 8 SYNDROME	0.024486933	1.6025146309292426
COFFIN-SIRIS SYNDROME 1; CSS1	0.024140603	1.5798495265599153
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.024066862	1.5750236452868562
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.023962893	1.5682195329195343
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.023933582	1.566301313665732
PHELAN-MCDERMID SYNDROME; PHMDS	0.023903192999999996	1.5643125461414646
PITT-HOPKINS SYNDROME	0.023780811	1.556303419577416
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.023773839999999997	1.55584721179132
LAMB-SHAFFER SYNDROME	0.023766212	1.555348007517566
GAPO SYNDROME; GAPOS	0.023734810999999998	1.553293011004699
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.023643050999999998	1.547287900338775
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.023643050999999998	1.547287900338775
Congenital disorder of glycosylation, type IIh	0.023572782	1.5426892394692915
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.023571182	1.5425845296058924
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.023458032999999996	1.5351796443973196
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.02332581	1.5265264867297033
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.023248512	1.5214678223415756
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.023191241999999997	1.517719863668543
RING CHROMOSOME 14 SYNDROME	0.023124752	1.5133685144076747
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5095289346041683
GENITOPATELLAR SYNDROME; GTPTS	0.023043862000000002	1.5080747763762166
FOCAL DERMAL HYPOPLASIA; FDH	0.02290501	1.498987792655806
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.02290501	1.498987792655806
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.022842492	1.494896385630825
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02280491	1.4924368818269154
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.0227273	1.487357799015425
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0227273	1.487357799015425
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0227273	1.487357799015425
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.0227273	1.487357799015425
#277950 WINCHESTER SYNDROME; WNCHRS	0.0227273	1.487357799015425
DERMOCHONDROCORNEAL DYSTROPHY	0.0227273	1.487357799015425
BAKER-GORDON SYNDROME; BAGOS	0.022542281999999997	1.4752495430739694
#156550 KNIEST DYSPLASIA	0.02251595	1.473526280497083
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.022513193	1.4733458523137142
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.022504259999999998	1.4727612440576252
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.022504259999999998	1.4727612440576252
FONTAINE PROGEROID SYNDROME; FPS	0.02238097	1.4646926946460976
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.022311040999999997	1.4601162846225861
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4543022040137006
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4543022040137006
EPILEPSY, HOT WATER, 1	0.0222222	1.4543022040137006
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4543022040137006
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.022036982	1.4421808593393204
MEIER-GORLIN SYNDROME 3; MGORS3	0.02161867	1.4148049891030081
#614976 CARPENTER SYNDROME 2; CRPT2	0.021537511999999998	1.4094937121694306
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.021268993	1.3919208447881832
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.021245633	1.3903920807825603
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.021222993	1.3889104362154663
CRANIOFRONTONASAL SYNDROME; CFNS	0.021089482000000003	1.3801729871078143
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.021045603	1.3773013845477653
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.021020841	1.3756808685243387
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.020827303	1.3630150325602846
CHROMOSOME 18Q DELETION SYNDROME	0.020804681000000002	1.3615345659791545
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.020727633000000002	1.3564922625071827
15q26 overgrowth syndrome	0.02069508	1.3543618748926682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.020627533	1.349941351678292
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.020619070000000003	1.349387501944577
COCKAYNE SYNDROME A; CSA	0.020525480999999998	1.3432626948160549
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.020353241999999997	1.331990743464833
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.020324102999999996	1.3300837805213461
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.020303263	1.3287199345505762
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.020266832999999998	1.3263358218483137
COFFIN-LOWRY SYNDROME; CLS	0.020201721	1.3220746539572974
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.020201721	1.3220746539572974
#278250 WRINKLY SKIN SYNDROME; WSS	0.02016959	1.3199718835692549
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.02016959	1.3199718835692549
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.020144450999999997	1.3183266952842647
AU-KLINE SYNDROME; AUKS	0.020129852	1.317371283224415
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.020101892999999996	1.3155415438051845
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.020098613	1.3153268885852172
GLASS SYNDROME	0.020022603	1.3103525156371256
AL-RAQAD SYNDROME; ARS	0.019932392	1.3044487772077045
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.01991284	1.3031692226769707
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.019811882000000003	1.2965621611838327
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.019733999999999998	1.2914652776955642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	1.290011250354942
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	1.290011250354942
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	1.290011250354942
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.290011250354942
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	1.290011250354942
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	1.290011250354942
FUMARASE DEFICIENCY; FMRD	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.019711782	1.290011250354942
COFFIN-SIRIS SYNDROME 7; CSS7	0.019688162000000002	1.2884654709965164
Retinitis pigmentosa with or without skeletal anomalies	0.019688162000000002	1.2884654709965164
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.019482651	1.2750160780359157
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.019422950999999997	1.271109091257846
PROTEUS SYNDROME	0.01928597	1.2621445526339474
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.019261359999999998	1.2605339840475438
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.019228699999999998	1.2583965939609147
BRITTLE CORNEA SYNDROME 2; BCS2	0.01916025	1.2539169751173829
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.0189807	1.2421665651340932
GOLDBERG-SHPRINTZEN SYNDROME	0.018882212000000002	1.2357211494925773
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2347845197644742
RHEUMATOID ARTHRITIS	0.0188679	1.2347845197644742
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2347845197644742
CARDIAC ARRHYTHMIA	0.0188679	1.2347845197644742
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2347845197644742
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2347845197644742
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2347845197644742
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2347845197644742
ALCOHOL DEPENDENCE	0.0188679	1.2347845197644742
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2347845197644742
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2347845197644742
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2347845197644742
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2347845197644742
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2347845197644742
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2347845197644742
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2347845197644742
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2347845197644742
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2347845197644742
PALMOMENTAL REFLEX	0.0188679	1.2347845197644742
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2347845197644742
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2347845197644742
TRANSSEXUALITY	0.0188679	1.2347845197644742
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2347845197644742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2347845197644742
269800 SENILE PLAQUE FORMATION	0.0188679	1.2347845197644742
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2347845197644742
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2347845197644742
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2347845197644742
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2347845197644742
THUMBS, CONGENITAL CLASPED	0.0188679	1.2347845197644742
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2347845197644742
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2347845197644742
ERYTHERMALGIA, PRIMARY	0.0188679	1.2347845197644742
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2347845197644742
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2347845197644742
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2347845197644742
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2347845197644742
CERVICAL RIB	0.0188679	1.2347845197644742
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2347845197644742
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2347845197644742
MYOPATHY, CONGENITAL	0.0188679	1.2347845197644742
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2347845197644742
DIASTEMATOMYELIA	0.0188679	1.2347845197644742
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2347845197644742
MOTION SICKNESS	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	1.2347845197644742
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2347845197644742
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2347845197644742
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	1.2347845197644742
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2347845197644742
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2347845197644742
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2347845197644742
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2347845197644742
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2347845197644742
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.01856237	1.214789516911818
608028 THAI SYMPHALANGISM SYNDROME	0.01856237	1.214789516911818
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.01856237	1.214789516911818
AL KAISSI SYNDROME; ALKAS	0.018517703	1.211866344744045
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.018507199999999998	1.211178989934496
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.018507199999999998	1.211178989934496
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.018507199999999998	1.211178989934496
KLEEFSTRA SYNDROME	0.018422501	1.2056359769844842
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.01826297	1.195195683723308
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.018125992	1.186231341430403
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.018061599999999997	1.1820172929779162
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.017917201	1.172567293249835
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.017901152	1.17151698787628
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.017787563	1.164083307455272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.017632632999999998	1.1539441204950323
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017632632999999998	1.1539441204950323
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.017632632999999998	1.1539441204950323
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.017632632999999998	1.1539441204950323
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.017632632999999998	1.1539441204950323
KNIEST-LIKE DYSPLASIA, LETHAL	0.01750675	1.145705875661134
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01728211	1.1310046108399354
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.017224341	1.1272239957782555
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.017152472000000002	1.122520625045373
MELNICK-NEEDLES SYNDROME	0.017117689999999998	1.120244363502411
BARTH SYNDROME; BTHS	0.017117689999999998	1.120244363502411
LISSENCEPHALY 8; LIS8	0.017114933	1.120063935319042
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01692544	1.1076628189783932
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.016911133	1.1067265164686135
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.016911133	1.1067265164686135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.016911133	1.1067265164686135
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.016911133	1.1067265164686135
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.016911133	1.1067265164686135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.016911133	1.1067265164686135
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.016911133	1.1067265164686135
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.016911133	1.1067265164686135
N-ACETYLASPARTATE DEFICIENCY; NACED	0.016911133	1.1067265164686135
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.016911133	1.1067265164686135
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.016890293	1.1053626704978436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.016890293	1.1053626704978436
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.016890292999999997	1.1053626704978434
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.016890292999999997	1.1053626704978434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.016788750999999998	1.0987173899045646
GAUCHER DISEASE, PERINATAL LETHAL	0.016788750999999998	1.0987173899045646
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.016788750999999998	1.0987173899045646
CRI-DU-CHAT SYNDROME	0.01675807	1.096709512830227
MENTAL RETARDATION, X-LINKED 106; MRX106	0.016716882	1.0940140191716823
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.016716882	1.0940140191716823
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.016716882	1.0940140191716823
CORNELIA DE LANGE SYNDROME 3	0.016685643	1.0919696245324844
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.016666903	1.0907432102574253
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.016666903	1.0907432102574253
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.016666902999999997	1.090743210257425
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.016609633	1.0869952515843928
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.082487361077743
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.082487361077743
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.01653323	1.0819951592761037
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.016475959999999998	1.078247200603071
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0777839903448607
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.0777839903448607
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.0777839903448607
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.0777839903448607
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.0777839903448607
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0777839903448607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.016465532999999997	1.0775648195120338
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.016465532999999997	1.0775648195120338
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.016465532999999997	1.0775648195120338
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.016465532999999997	1.0775648195120338
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.016465532999999997	1.0775648195120338
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.016465532999999997	1.0775648195120338
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.016465532999999997	1.0775648195120338
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.016465532999999997	1.0775648195120338
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.016465532999999997	1.0775648195120338
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.016465532999999997	1.0775648195120338
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.016384993	1.0722939867631942
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.016384993	1.0722939867631942
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.016384993	1.0722939867631942
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.016384993	1.0722939867631942
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.016308589999999998	1.067293894454905
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01625132	1.0635459357818728
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.016161603	1.057674526522776
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.016104333	1.0539265678497434
CEREBELLOPARENCHYMAL DISORDER II	0.016067250999999998	1.0514997858781456
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.016067250999999998	1.0514997858781456
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.016067250999999998	1.0514997858781456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.016046411	1.0501359399073757
LATERAL MENINGOCELE SYNDROME	0.01602793	1.0489264755414545
MEIER-GORLIN SYNDROME 6; MGORS6	0.01602793	1.0489264755414545
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.015995382	1.0467964151452633
PEROXISOME BIOGENESIS DISORDER 5B	0.015995382	1.0467964151452633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.015995382	1.0467964151452633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.015995382	1.0467964151452633
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.015995382	1.0467964151452633
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.015974542	1.0454325691744935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.015872999999999998	1.0387872885812146
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.015872999999999998	1.0387872885812146
Myhre syndrome	0.015841761	1.0367428939420167
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.015769892	1.0320395232091344
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.015751151999999997	1.030813108934075
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.015751151999999997	1.030813108934075
PAINE SYNDROME	0.015625	1.022557259754393
CARNOSINEMIA	0.015625	1.022557259754393
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.022557259754393
HYDROXYLYSINURIA	0.015625	1.022557259754393
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.022557259754393
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.022557259754393
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.022557259754393
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.022557259754393
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	1.022557259754393
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.022557259754393
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.015621650999999999	1.022338088921566
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.022338088921566
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.015621650999999999	1.022338088921566
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.015621650999999999	1.022338088921566
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.022338088921566
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.015621650999999999	1.022338088921566
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.015621650999999999	1.022338088921566
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.015621650999999999	1.022338088921566
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.015621650999999999	1.022338088921566
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.015621650999999999	1.022338088921566
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.015621650999999999	1.022338088921566
NEUROFIBROMATOSIS, TYPE I	0.015621650999999999	1.022338088921566
XYLOSIDASE DEFICIENCY	0.015621650999999999	1.022338088921566
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.015600092999999999	1.020927254399596
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.0176347181886838
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	1.0176347181886838
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	1.0176347181886838
LISSENCEPHALY, X-LINKED, 2	0.015541111	1.0170672561727265
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.015469242000000001	1.0123638854398442
COFFIN-SIRIS SYNDROME 2; CSS2	0.015405383000000002	1.0081847184606023
POTOCKI-LUPSKI SYNDROME	0.015376702999999999	1.0063077941591776
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.015355299999999999	1.0049071034052242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.015319432999999999	1.0025598354861451
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.015317721	1.0024477959323086
CHROMOSOME 17P13.1 DELETION SYNDROME	0.015245852	0.9977444251994261
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.015181781	0.9935513841632836
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.015151499999999998	0.9915696845547957
DEAFNESS, X-LINKED 5; DFNX5	0.015151499999999998	0.9915696845547957
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.015151499999999998	0.9915696845547957
HUNTINGTON DISEASE-LIKE 1	0.015151499999999998	0.9915696845547957
SYRINGOMYELIA, ISOLATED	0.015151499999999998	0.9915696845547957
MYELOCEREBELLAR DISORDER	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA 40; SCA40	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA 41; SCA41	0.015151499999999998	0.9915696845547957
KURU, SUSCEPTIBILITY TO	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA 37; SCA37	0.015151499999999998	0.9915696845547957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.015151499999999998	0.9915696845547957
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.015151499999999998	0.9915696845547957
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.015151499999999998	0.9915696845547957
VERVERI-BRADY SYNDROME; VERBRAS	0.015151499999999998	0.9915696845547957
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.015151499999999998	0.9915696845547957
CHIARI MALFORMATION TYPE I	0.015151499999999998	0.9915696845547957
SPINOCEREBELLAR ATAXIA 42	0.015151499999999998	0.9915696845547957
HEART AND BRAIN MALFORMATION SYNDROME	0.015104733	0.988509080691312
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.015016323	0.9827232063018794
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.014955903	0.9787691000852803
PETERS-PLUS SYNDROME; PTRPLS	0.014955903	0.9787691000852803
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01492601	0.9768127926186667
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01492601	0.9768127926186667
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.014881343	0.973889620450894
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014881343	0.973889620450894
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.014879893	0.9737947271371887
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.014879893	0.9737947271371887
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.01485	0.971838419670575
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.014849999999999999	0.9718384196705749
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.9624079875982161
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.9624079875982161
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.9624079875982161
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.9624079875982161
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.9624079875982161
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.9624079875982161
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.9624079875982161
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.9624079875982161
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.9624079875982161
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.9624079875982161
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.9624079875982161
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.9624079875982161
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.014655253	0.9590934623159901
STROMME SYNDROME; STROMS	0.01462536	0.9571371548493767
600736 VELOFACIOSKELETAL SYNDROME	0.01462536	0.9571371548493767
JOUBERT SYNDROME 24	0.014605871999999999	0.9558617887131785
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.014561501000000001	0.9529579878701346
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014532820999999998	0.95108106356871
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.014489632000000002	0.9482546171372521
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.014485491	0.947983614922043
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.014485491	0.947983614922043
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.014431863	0.944474002075572
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.014413622000000001	0.9432802441891606
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.014413622000000001	0.9432802441891606
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01440197	0.9425176946089584
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.01440197	0.9425176946089584
SECKEL SYNDROME 5; SCKL5	0.01440197	0.9425176946089584
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.01440197	0.9425176946089584
CHROMOSOME 16Q22 DELETION SYNDROME	0.014188982	0.928578979367962
CHROMOSOME 9P DELETION SYNDROME	0.014188982	0.928578979367962
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.014172441000000001	0.9274964757114118
ADAMS-OLIVER SYNDROME 5; AOS5	0.014112020999999999	0.9235423694948126
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.014040152	0.9188389987619302
SECKEL SYNDROME 1; SCKL1	0.014037461	0.9186628898604263
GABRIELE-DE VRIES SYNDROME; GADEVS	0.013965592	0.9139595191275438
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.013965592	0.9139595191275438
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.013964141999999999	0.9138646258138385
PALLISTER-KILLIAN SYNDROME	0.013811371	0.9038667317255226
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.01376199	0.9006350581227109
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.013739502	0.8991633609926402
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.013645750000000002	0.8930278865467847
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.013645750000000002	0.8930278865467847
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.013645750000000002	0.8930278865467847
KEIPERT SYNDROME; KPTS	0.013645750000000002	0.8930278865467847
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01356974	0.8880535135986929
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01356974	0.8880535135986929
HYDROLETHALUS SYNDROME 1	0.01356974	0.8880535135986929
TRISOMY 18-LIKE SYNDROME	0.0133451	0.8733522487774944
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.0133451	0.8733522487774944
SIMOSA CRANIOFACIAL SYNDROME	0.0133451	0.8733522487774944
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.01325669	0.8675663743880617
BEHR SYNDROME	0.01325669	0.8675663743880617
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.01325669	0.8675663743880617
DYSTONIA 16; DYT16	0.01325669	0.8675663743880617
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01325669	0.8675663743880617
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.01325669	0.8675663743880617
MAST SYNDROME	0.01325669	0.8675663743880617
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.01325669	0.8675663743880617
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.013253932999999999	0.8673859462046924
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013253932999999999	0.8673859462046924
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.013253932999999999	0.8673859462046924
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.013253932999999999	0.8673859462046924
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.013253932999999999	0.8673859462046924
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.01312171	0.8587327885370761
MAXILLOFACIAL DYSOSTOSIS	0.01312171	0.8587327885370761
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01312171	0.8587327885370761
LOEYS-DIETZ SYNDROME 3; LDS3	0.01312026	0.8586378952233709
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.01312026	0.8586378952233709
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01306444	0.8549848298640436
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01306444	0.8549848298640436
TEMTAMY SYNDROME; TEMTYS	0.012970612999999999	0.8488444471433411
OMODYSPLASIA 1; OMOD1	0.01289562	0.8439366304021725
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.01289562	0.8439366304021725
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01289562	0.8439366304021725
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.01289562	0.8439366304021725
MEND SYNDROME; MEND	0.012748633	0.8343172624700433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.012748633	0.8343172624700433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.012748633	0.8343172624700433
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.012748633	0.8343172624700433
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.012748633	0.8343172624700433
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.012748633	0.8343172624700433
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01267223	0.8293171701617542
ARTERIAL TORTUOSITY SYNDROME	0.01267223	0.8293171701617542
CHARGE SYNDROME	0.01267223	0.8293171701617542
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.01267223	0.8293171701617542
POPOV-CHANG SYNDROME; POPCHAS	0.012338182	0.8074558448813425
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.012338182	0.8074558448813425
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.012338182	0.8074558448813425
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012338182	0.8074558448813425
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.012338182	0.8074558448813425
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.012338182	0.8074558448813425
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.012338182	0.8074558448813425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.012338182	0.8074558448813425
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.012278252	0.8035338060604093
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.012278252	0.8035338060604093
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.011963732999999999	0.7829505301064448
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.011963732999999999	0.7829505301064448
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.011963732999999999	0.7829505301064448
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.011963732999999999	0.7829505301064448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.011963732999999999	0.7829505301064448
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.011963732999999999	0.7829505301064448
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.011963732999999999	0.7829505301064448
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.011963732999999999	0.7829505301064448
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.011963732999999999	0.7829505301064448
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.011963732999999999	0.7829505301064448
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.011963732999999999	0.7829505301064448
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.011963732999999999	0.7829505301064448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.011963732999999999	0.7829505301064448
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.011963732999999999	0.7829505301064448
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.011963732999999999	0.7829505301064448
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.011904751	0.7790905318795757
OROFACIODIGITAL SYNDROME I; OFD1	0.011902091	0.778916451731675
POTOCKI-SHAFFER SYNDROME	0.011902091	0.778916451731675
AYME-GRIPP SYNDROME; AYGRP	0.011902091	0.778916451731675
FORSYTHE-WAKELING SYNDROME; FWS	0.011832882000000001	0.7743871611466933
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.011832882000000001	0.7743871611466933
HADZISELIMOVIC SYNDROME	0.011832882000000001	0.7743871611466933
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.011832882000000001	0.7743871611466933
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.011832882000000001	0.7743871611466933
ALAZAMI-YUAN SYNDROME	0.011832882000000001	0.7743871611466933
FRONTOOCULAR SYNDROME	0.011832882000000001	0.7743871611466933
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.011832882000000001	0.7743871611466933
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.011832882000000001	0.7743871611466933
ELSAHY-WATERS SYNDROME; ESWS	0.011830222000000001	0.7742130809987926
Aarskog-Scott syndrome	0.011830222000000001	0.7742130809987926
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.011826081	0.7739420787835835
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.011826081	0.7739420787835835
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.011768811	0.7701941201105509
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011660623	0.7631139009221791
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.011660623	0.7631139009221791
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.011660623	0.7631139009221791
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.011660623	0.7631139009221791
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.011660623	0.7631139009221791
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.011660623	0.7631139009221791
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.011660623	0.7631139009221791
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.011621431	0.7605490328182243
COFFIN-SIRIS SYNDROME 6; CSS6	0.011549562	0.7558456620853418
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.011545421	0.7555746598701327
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.011494299999999999	0.7522291142908748
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.011494299999999999	0.7522291142908748
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.011494299999999999	0.7522291142908748
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.011494299999999999	0.7522291142908748
BETHLEM MYOPATHY 2; BTHLM2	0.011494299999999999	0.7522291142908748
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.011494299999999999	0.7522291142908748
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.011494299999999999	0.7522291142908748
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.011494299999999999	0.7522291142908748
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.011494299999999999	0.7522291142908748
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.011494299999999999	0.7522291142908748
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.011494299999999999	0.7522291142908748
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.011494299999999999	0.7522291142908748
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.011494299999999999	0.7522291142908748
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.011494299999999999	0.7522291142908748
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.011494299999999999	0.7522291142908748
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.011473552	0.7508712891372502
DESANTO-SHINAWI SYNDROME	0.011468373	0.7505323563981611
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.011468373	0.7505323563981611
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.011468373	0.7505323563981611
NOONAN SYNDROME 6; NS6	0.011248912	0.7361700243160516
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.011248912	0.7361700243160516
DESBUQUOIS DYSPLASIA 1	0.01115371	0.729939656556491
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.011119850999999998	0.7277237995159772
MENTAL RETARDATION, X-LINKED 82	0.011119850999999998	0.7277237995159772
Angelman syndrome (Type 1)	0.011119850999999998	0.7277237995159772
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.011119850999999998	0.7277237995159772
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.011119850999999998	0.7277237995159772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.011119850999999998	0.7277237995159772
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.011119850999999998	0.7277237995159772
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.011119850999999998	0.7277237995159772
AUTISM	0.011119850999999998	0.7277237995159772
Angelman syndrome (Type 2)	0.011119850999999998	0.7277237995159772
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.011119850999999998	0.7277237995159772
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.011119850999999998	0.7277237995159772
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.011119850999999998	0.7277237995159772
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.011119850999999998	0.7277237995159772
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.011119850999999998	0.7277237995159772
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.011119850999999998	0.7277237995159772
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.011119850999999998	0.7277237995159772
KRABBE DISEASE	0.011119850999999998	0.7277237995159772
RETT SYNDROME; RTT	0.011119850999999998	0.7277237995159772
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.011119850999999998	0.7277237995159772
EPILEPSY, READING	0.011119850999999998	0.7277237995159772
EPILEPSY, BENIGN OCCIPITAL	0.011119850999999998	0.7277237995159772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.011119850999999998	0.7277237995159772
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.011119850999999998	0.7277237995159772
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.011119850999999998	0.7277237995159772
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.011119850999999998	0.7277237995159772
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.011119850999999998	0.7277237995159772
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.011047982	0.7230204287830949
DIGEORGE SYNDROME; DGS	0.011018893	0.7211167380228392
IMMUNODEFICIENCY 49; IMD49	0.011018893	0.7211167380228392
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.011018893	0.7211167380228392
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011018893	0.7211167380228392
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.011018893	0.7211167380228392
WOODHOUSE-SAKATI SYNDROME	0.010989	0.7191604305562256
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.010989	0.7191604305562256
RUIJS-AALFS SYNDROME; RJALS	0.010989	0.7191604305562256
WARBURG MICRO SYNDROME 2; WARBM2	0.010989	0.7191604305562256
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.010989	0.7191604305562256
CEREBROOCULONASAL SYNDROME	0.010989	0.7191604305562256
%608572 BURN-MCKEOWN SYNDROME	0.010989	0.7191604305562256
3q29 microdeletion syndrome	0.010989	0.7191604305562256
MENTAL RETARDATION, X-LINKED 45	0.010989	0.7191604305562256
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.010989	0.7191604305562256
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.010989	0.7191604305562256
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.010989	0.7191604305562256
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.010989	0.7191604305562256
NANCE-HORAN SYNDROME	0.010989	0.7191604305562256
ROBERTS SYNDROME; RBS	0.01098634	0.718986350408325
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.01098634	0.718986350408325
BASAL CELL NEVUS SYNDROME	0.010929069999999999	0.7152383917352922
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.010929069999999999	0.7152383917352922
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.010816741	0.7078871703317114
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.010816741	0.7078871703317114
TENORIO SYNDROME; TNORS	0.010816741	0.7078871703317114
ALZHEIMER DISEASE 3; AD	0.010816741	0.7078871703317114
METACHROMATIC LEUKODYSTROPHY	0.010816741	0.7078871703317114
KUFOR-RAKEB SYNDROME	0.010816741	0.7078871703317114
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.010816741	0.7078871703317114
CHOREOATHETOSIS, FAMILIAL INVERTED	0.010816741	0.7078871703317114
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.010816741	0.7078871703317114
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.703183799598829
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.703183799598829
HYDROCEPHALUS, NORMAL-PRESSURE	0.010744872	0.703183799598829
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010744872	0.703183799598829
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.010744872	0.703183799598829
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010744872	0.703183799598829
HYPERMANGANESEMIA WITH DYSTONIA 2	0.010744872	0.703183799598829
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.010744872	0.703183799598829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.703183799598829
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.010629669999999999	0.6956445585467825
LOEYS-DIETZ SYNDROME 5	0.010629669999999999	0.6956445585467825
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010624491	0.6953056258076934
OCULODENTODIGITAL DYSPLASIA; ODDD	0.010624491	0.6953056258076934
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.010624491	0.6953056258076934
MECKEL SYNDROME, TYPE 10; MKS10	0.010624491	0.6953056258076934
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.010624491	0.6953056258076934
BARAITSER-WINTER SYNDROME 2; BRWS2	0.010624491	0.6953056258076934
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.010624491	0.6953056258076934
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.010552622000000001	0.6906022550748111
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.010552622000000001	0.6906022550748111
OROFACIODIGITAL SYNDROME XIV; OFD14	0.010552622000000001	0.6906022550748111
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.010204099999999999	0.6677936981926271
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.010204099999999999	0.6677936981926271
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.010204099999999999	0.6677936981926271
SCHIZOPHRENIA	0.010204099999999999	0.6677936981926271
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.010204099999999999	0.6677936981926271
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.010204099999999999	0.6677936981926271
SACCHAROPINURIA	0.010204099999999999	0.6677936981926271
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.010204099999999999	0.6677936981926271
ELECTROENCEPHALOGRAPHIC PATTERNS	0.010204099999999999	0.6677936981926271
MUCOPOLYSACCHARIDOSIS, TYPE II	0.010175011	0.6658900074323715
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.010175011	0.6658900074323715
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010103142	0.6611866366994891
#300555 DENT DISEASE 2	0.010103142	0.6611866366994891
TOWNES-BROCKS SYNDROME 1; TBS1	0.010103142	0.6611866366994891
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.010103142	0.6611866366994891
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.6479570690083614
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00990099	0.6479570690083614
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.6479570690083614
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.6479570690083614
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.6479570690083614
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.6479570690083614
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.6479570690083614
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00990099	0.6479570690083614
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.6479570690083614
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.6479570690083614
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.6479570690083614
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.6479570690083614
NEMALINE MYOPATHY 6	0.00990099	0.6479570690083614
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00990099	0.6479570690083614
NONAKA MYOPATHY	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.6479570690083614
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00990099	0.6479570690083614
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00990099	0.6479570690083614
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.6479570690083614
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.6479570690083614
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.6479570690083614
DYSTONIA 23; DYT23	0.00990099	0.6479570690083614
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.6479570690083614
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.6479570690083614
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.6479570690083614
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.6479570690083614
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00990099	0.6479570690083614
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00990099	0.6479570690083614
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00990099	0.6479570690083614
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.6479570690083614
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.6479570690083614
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00990099	0.6479570690083614
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.6479570690083614
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.6479570690083614
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00990099	0.6479570690083614
KENNERKNECHT SYNDROME	0.00970874	0.6353755244843434
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00970874	0.6353755244843434
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00970874	0.6353755244843434
BRANCHIOOTIC SYNDROME 2	0.00970874	0.6353755244843434
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00970874	0.6353755244843434
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00970874	0.6353755244843434
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00970874	0.6353755244843434
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00970874	0.6353755244843434
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00970874	0.6353755244843434
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00970874	0.6353755244843434
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00970874	0.6353755244843434
VAN BOGAERT-HOZAY SYNDROME	0.00970874	0.6353755244843434
FIBROCHONDROGENESIS 1; FBCG1	0.00970874	0.6353755244843434
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00970874	0.6353755244843434
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00970874	0.6353755244843434
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00970874	0.6353755244843434
184705 STEINFELD SYNDROME	0.00970874	0.6353755244843434
RESTRICTIVE DERMOPATHY, LETHAL	0.00970874	0.6353755244843434
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00970874	0.6353755244843434
NEU-LAXOVA SYNDROME 2; NLS2	0.00970874	0.6353755244843434
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00970874	0.6353755244843434
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00970874	0.6353755244843434
BARBER-SAY SYNDROME; BBRSAY	0.00970874	0.6353755244843434
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.009557643000000001	0.6254871830906084
ADAMS-OLIVER SYNDROME 1; AOS1	0.009557643000000001	0.6254871830906084
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009333003	0.6107859182694098
MUSCULAR HYPERTONIA, LETHAL	0.00925926	0.6059599061090215
FLOATING-HARBOR SYNDROME	0.00925926	0.6059599061090215
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00925926	0.6059599061090215
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.00925926	0.6059599061090215
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00925926	0.6059599061090215
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00925926	0.6059599061090215
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00925926	0.6059599061090215
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.00925926	0.6059599061090215
Lipodystrophy, congenital generalized, type 1	0.00925926	0.6059599061090215
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00925926	0.6059599061090215
Lipodystrophy, congenital generalized, type 2	0.00925926	0.6059599061090215
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, TYPE I	0.00925926	0.6059599061090215
HURLER-SCHEIE SYNDROME	0.00925926	0.6059599061090215
HUNTER-MACDONALD SYNDROME	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00925926	0.6059599061090215
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00925926	0.6059599061090215
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00925926	0.6059599061090215
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009256993	0.6058115453213182
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.009109612999999999	0.5961664580289916
Muenke syndrome	0.009109612999999999	0.5961664580289916
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.008976333	0.5874441264078674
MIRAGE SYNDROME; MIRAGE	0.008976333	0.5874441264078674
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.008808963	0.5764908202597014
WIEDEMANN-STEINER SYNDROME; WDSTS	0.008808963	0.5764908202597014
Helsmoortel-van der Aa syndrome	0.008808963	0.5764908202597014
ZTTK SYNDROME; ZTTKS	0.008808963	0.5764908202597014
CHROMOSOME 10Q26 DELETION SYNDROME	0.008808963	0.5764908202597014
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.008751693	0.5727428615866689
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.008713761	0.5702604525001408
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.008528303	0.5581234013462507
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.008489121	0.5555591876789423
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.008417252	0.5508558169460598
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008413111000000001	0.5505848147308506
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.008341241999999999	0.545881443997968
TARP SYNDROME; TARPS	0.008341241999999999	0.545881443997968
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.008265731	0.540939727438524
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.008265731	0.540939727438524
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.008208461	0.5371917687654915
%300712 CRANIOFACIOSKELETAL SYNDROME	0.008193862	0.5362363567056416
ROIFMAN SYNDROME; RFMN	0.008193862	0.5362363567056416
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.008132450999999999	0.5322173958173998
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.008132450999999999	0.5322173958173998
COSTELLO SYNDROME; CSTLO	0.008117852	0.53126198375755
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.008060582	0.5275140250845174
SAUL-WILSON SYNDROME; SWILS	0.008060582	0.5275140250845174
311450 PALLISTER W SYNDROME;;W SYNDROME	0.007965081	0.521264089669234
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.007965081	0.521264089669234
SPINOCEREBELLAR ATAXIA 47; SCA47	0.007907811	0.5175161309962014
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.007893212	0.5165607189363515
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.007893212	0.5165607189363515
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.007893212	0.5165607189363515
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.007893212	0.5165607189363515
OGDEN SYNDROME; OGDNS	0.007893212	0.5165607189363515
JOUBERT SYNDROME 10	0.007893212	0.5165607189363515
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.007835941999999999	0.5128127602633188
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00779801	0.5103303511767907
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00779801	0.5103303511767907
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00779801	0.5103303511767907
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00779801	0.5103303511767907
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00779801	0.5103303511767907
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00779801	0.5103303511767907
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00779801	0.5103303511767907
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00779801	0.5103303511767907
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00779801	0.5103303511767907
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00779801	0.5103303511767907
MULTIPLE SYNOSTOSES SYNDROME 2	0.00779801	0.5103303511767907
#612576 CHROMOSOME 17P13.3, TELOMERIC, DUPLICATION SYNDROME;;SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	0.00779801	0.5103303511767907
ATELOSTEOGENESIS, TYPE I; AO1	0.00779801	0.5103303511767907
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00779801	0.5103303511767907
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0076844209999999994	0.5028966707557831
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0076844209999999994	0.5028966707557831
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0076844209999999994	0.5028966707557831
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0076844209999999994	0.5028966707557831
CRANIOECTODERMAL DYSPLASIA 1	0.00757337	0.49562908635559216
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00757337	0.49562908635559216
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00757337	0.49562908635559216
FRONTONASAL DYSPLASIA 1; FND1	0.00757337	0.49562908635559216
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00757337	0.49562908635559216
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00757337	0.49562908635559216
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00757337	0.49562908635559216
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00757337	0.49562908635559216
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00757337	0.49562908635559216
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00749736	0.49065471340750055
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00749736	0.49065471340750055
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00749736	0.49065471340750055
TEEBI-SHALTOUT SYNDROME; TBSH	0.00749736	0.49065471340750055
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00749736	0.49065471340750055
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.007349980000000001	0.481009626115174
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.007349980000000001	0.481009626115174
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00729271	0.4772616674421414
#100800 ACHONDROPLASIA; ACH	0.00729271	0.4772616674421414
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00729271	0.4772616674421414
ODONTOCHONDRODYSPLASIA; ODCD	0.00729271	0.4772616674421414
MARTSOLF SYNDROME	0.007273969999999999	0.4760352531670823
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.007273969999999999	0.4760352531670823
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.007273969999999999	0.4760352531670823
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.007273969999999999	0.4760352531670823
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.007273969999999999	0.4760352531670823
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.007273969999999999	0.4760352531670823
Ullrich congenital muscular dystrophy 1	0.0072166999999999995	0.4722872944940497
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.0072166999999999995	0.4722872944940497
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0072166999999999995	0.4722872944940497
EHLERS-DANLOS SYNDROME, TYPE VI	0.0072166999999999995	0.4722872944940497
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0072166999999999995	0.4722872944940497
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.0072166999999999995	0.4722872944940497
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.0072166999999999995	0.4722872944940497
Contractural arachnodactyly, congenital	0.0072166999999999995	0.4722872944940497
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0072166999999999995	0.4722872944940497
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0072166999999999995	0.4722872944940497
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.0072166999999999995	0.4722872944940497
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.0072166999999999995	0.4722872944940497
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0070493299999999995	0.46133398834588374
FRONTOMETAPHYSEAL DYSPLASIA	0.0070493299999999995	0.46133398834588374
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0070493299999999995	0.46133398834588374
HYPERTELORISM, TEEBI TYPE; TBHS	0.0070493299999999995	0.46133398834588374
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0070493299999999995	0.46133398834588374
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.0070493299999999995	0.46133398834588374
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0070493299999999995	0.46133398834588374
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0070493299999999995	0.46133398834588374
KOSAKI OVERGROWTH SYNDROME; KOGS	0.0070493299999999995	0.46133398834588374
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0070493299999999995	0.46133398834588374
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0070493299999999995	0.46133398834588374
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00699206	0.4575860296728513
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.00699206	0.4575860296728513
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.006768669999999999	0.442966569432433
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.006768669999999999	0.442966569432433
SOTOS SYNDROME 2	0.006768669999999999	0.442966569432433
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.005696643	0.3728091939762589
GRACILE BONE DYSPLASIA; GCLEB	0.005696643	0.3728091939762589
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.005620633	0.3678348210281672
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.005620633	0.3678348210281672
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.005620633	0.3678348210281672
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.005620633	0.3678348210281672
JABERI-ELAHI SYNDROME; JABELS	0.005620633	0.3678348210281672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.005620633	0.3678348210281672
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005620633	0.3678348210281672
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005620633	0.3678348210281672
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.005620633	0.3678348210281672
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005620633	0.3678348210281672
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005620633	0.3678348210281672
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.005395993	0.3531335562069687
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.005395993	0.3531335562069687
BARAITSER-WINTER SYNDROME 1; BRWS1	0.005395993	0.3531335562069687
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.005395993	0.3531335562069687
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.005395993	0.3531335562069687
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.005395993	0.3531335562069687
CHROMOSOME 1p35 DELETION SYNDROME	0.005395993	0.3531335562069687
BOHRING-OPITZ SYNDROME	0.005395993	0.3531335562069687
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.005395993	0.3531335562069687
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.005395993	0.3531335562069687
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005395993	0.3531335562069687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005395993	0.3531335562069687
OCULOECTODERMAL SYNDROME; OES	0.005395993	0.3531335562069687
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.005395993	0.3531335562069687
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.005395993	0.3531335562069687
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.005395993	0.3531335562069687
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.005395993	0.3531335562069687
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005395993	0.3531335562069687
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005395993	0.3531335562069687
C SYNDROME	0.005395993	0.3531335562069687
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.005395993	0.3531335562069687
KABUKI SYNDROME 1	0.005395993	0.3531335562069687
611961 STEVENSON-CAREY SYNDROME	0.005172603	0.3385140959665505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005172603	0.3385140959665505
LUSCAN-LUMISH SYNDROME; LLS	0.005172603	0.3385140959665505
CHROMOSOME 19p13.13 DELETION SYNDROME	0.005172603	0.3385140959665505
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.005172603	0.3385140959665505
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.005172603	0.3385140959665505
GABA-TRANSAMINASE DEFICIENCY	0.005172603	0.3385140959665505
#602398 DESMOSTEROLOSIS	0.005172603	0.3385140959665505
CHROMOSOME 16p13.3 DELETION SYNDROME	0.005172603	0.3385140959665505
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.005172603	0.3385140959665505
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.005172603	0.3385140959665505
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.005172603	0.3385140959665505
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005172603	0.3385140959665505
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.005172603	0.3385140959665505
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005172603	0.3385140959665505
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.005172603	0.3385140959665505
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005172603	0.3385140959665505
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.005172603	0.3385140959665505
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.005115333	0.33476613729351795
KETOADIPICACIDURIA	0.005115333	0.33476613729351795
PRADER-WILLI SYNDROME; PWS	0.005115333	0.33476613729351795
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.005115333	0.33476613729351795
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.005115333	0.33476613729351795
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.005115333	0.33476613729351795
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.005115333	0.33476613729351795
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.005115333	0.33476613729351795
CODAS SYNDROME	0.005115333	0.33476613729351795
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.005115333	0.33476613729351795
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.005115333	0.33476613729351795
VICI SYNDROME; VICIS	0.005115333	0.33476613729351795
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.005115333	0.33476613729351795
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004852761000000001	0.31758246338579127
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.004852761000000001	0.31758246338579127
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004852761000000001	0.31758246338579127
CRANIOSYNOSTOSIS 2	0.004852761000000001	0.31758246338579127
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.004852761000000001	0.31758246338579127
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004852761000000001	0.31758246338579127
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.004852761000000001	0.31758246338579127
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004852761000000001	0.31758246338579127
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.004780892	0.31287909265290875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.004780892	0.31287909265290875
CHOPS SYNDROME; CHOPS	0.004780892	0.31287909265290875
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.004780892	0.31287909265290875
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004780892	0.31287909265290875
BARDET-BIEDL SYNDROME 1; BBS1	0.004780892	0.31287909265290875
OROFACIODIGITAL SYNDROME VI	0.004780892	0.31287909265290875
BARATELA-SCOTT SYNDROME	0.004780892	0.31287909265290875
BARDET-BIEDL SYNDROME 17; BBS17	0.004780892	0.31287909265290875
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.004780892	0.31287909265290875
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.004780892	0.31287909265290875
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004780892	0.31287909265290875
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.004780892	0.31287909265290875
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.004780892	0.31287909265290875
BARDET-BIEDL SYNDROME 3; BBS3	0.004780892	0.31287909265290875
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.004780892	0.31287909265290875
Temtamy preaxial brachydactyly syndrome	0.004780892	0.31287909265290875
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.004776751	0.3126080904376996
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.004776751	0.3126080904376996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.004776751	0.3126080904376996
MARDEN-WALKER SYNDROME	0.004776751	0.3126080904376996
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.004776751	0.3126080904376996
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.004776751	0.3126080904376996
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.004704882	0.30790471970481714
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.004704882	0.30790471970481714
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004704882	0.30790471970481714
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004704882	0.30790471970481714
SECKEL SYNDROME 9; SCKL9	0.004704882	0.30790471970481714
DIAPHANOSPONDYLODYSOSTOSIS	0.004704882	0.30790471970481714
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.004704882	0.30790471970481714
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004704882	0.30790471970481714
RICHARDS-RUNDLE SYNDROME; RRNS	0.004704882	0.30790471970481714
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004704882	0.30790471970481714
RAHMAN SYNDROME	0.004704882	0.30790471970481714
LARSEN-LIKE SYNDROME	0.004704882	0.30790471970481714
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.004704882	0.30790471970481714
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004704882	0.30790471970481714
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.004704882	0.30790471970481714
OHDO SYNDROME	0.004552111	0.29790682561650106
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.004552111	0.29790682561650106
FILIPPI SYNDROME; FLPIS	0.004552111	0.29790682561650106
GLUTAMINE DEFICIENCY, CONGENITAL	0.004552111	0.29790682561650106
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004552111	0.29790682561650106
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.004552111	0.29790682561650106
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004552111	0.29790682561650106
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.004552111	0.29790682561650106
ZUNICH NEUROECTODERMAL SYNDROME	0.004552111	0.29790682561650106
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004552111	0.29790682561650106
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004552111	0.29790682561650106
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004552111	0.29790682561650106
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004552111	0.29790682561650106
RENPENNING SYNDROME 1; RENS1	0.004552111	0.29790682561650106
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.004552111	0.29790682561650106
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.004480242	0.2932034548836186
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004480242	0.2932034548836186
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.004480242	0.2932034548836186
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.004480242	0.2932034548836186
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004480242	0.2932034548836186
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.004480242	0.2932034548836186
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.004480242	0.2932034548836186
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.004480242	0.2932034548836186
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.004480242	0.2932034548836186
CHROMOSOME 18P DELETION SYNDROME	0.004480242	0.2932034548836186
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004480242	0.2932034548836186
SWEENEY-COX SYNDROME; SWCOS	0.004480242	0.2932034548836186
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004480242	0.2932034548836186
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.004480242	0.2932034548836186
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.004480242	0.2932034548836186
ALAZAMI SYNDROME; ALAZS	0.004480242	0.2932034548836186
STEEL SYNDROME; STLS	0.004480242	0.2932034548836186
ATKIN-FLAITZ SYNDROME	0.004328721	0.2832873653760829
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004328721	0.2832873653760829
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.004328721	0.2832873653760829
CLARK-BARAITSER SYNDROME	0.004328721	0.2832873653760829
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004328721	0.2832873653760829
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004328721	0.2832873653760829
AUTISM, SUSCEPTIBILITY TO, 18	0.004328721	0.2832873653760829
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.004328721	0.2832873653760829
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.004271451	0.27953940670305033
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.004271451	0.27953940670305033
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.004271451	0.27953940670305033
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004271451	0.27953940670305033
EPISODIC ATAXIA, TYPE 6	0.004271451	0.27953940670305033
CYCLIC VOMITING SYNDROME	0.004271451	0.27953940670305033
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.004271451	0.27953940670305033
MICROPHTHALMIA, SYNDROMIC 1	0.004271451	0.27953940670305033
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004271451	0.27953940670305033
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.004271451	0.27953940670305033
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.004271451	0.27953940670305033
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004271451	0.27953940670305033
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.004271451	0.27953940670305033
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.004271451	0.27953940670305033
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.004271451	0.27953940670305033
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.004271451	0.27953940670305033
LISSENCEPHALY, X-LINKED, 1; LISX1	0.004271451	0.27953940670305033
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.004271451	0.27953940670305033
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.004271451	0.27953940670305033
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.004271451	0.27953940670305033
LISSENCEPHALY 3; LIS3	0.004271451	0.27953940670305033
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004271451	0.27953940670305033
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.004271451	0.27953940670305033
RITSCHER-SCHINZEL SYNDROME 1	0.004256852	0.2785839946432005
FRIAS SYNDROME	0.004256852	0.2785839946432005
NOONAN SYNDROME 2; NS2	0.004256852	0.2785839946432005
NOONAN SYNDROME 9; NS9	0.004256852	0.2785839946432005
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.004256852	0.2785839946432005
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004256852	0.2785839946432005
THAUVIN-ROBINET-FAIVRE SYNDROME	0.004256852	0.2785839946432005
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.004256852	0.2785839946432005
NOONAN SYNDROME 3; NS3	0.004256852	0.2785839946432005
NOONAN SYNDROME 11; NS11	0.004256852	0.2785839946432005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004256852	0.2785839946432005
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004256852	0.2785839946432005
CHROMOSOME 15q25 DELETION SYNDROME	0.004256852	0.2785839946432005
CREE MENTAL RETARDATION SYNDROME	0.004256852	0.2785839946432005
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004256852	0.2785839946432005
NOONAN SYNDROME 5; NS5	0.004256852	0.2785839946432005
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004256852	0.2785839946432005
MEVALONIC ACIDURIA; MEVA	0.004256852	0.2785839946432005
XIA-GIBBS SYNDROME	0.004256852	0.2785839946432005
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004256852	0.2785839946432005
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004256852	0.2785839946432005
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.004256852	0.2785839946432005
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.004256852	0.2785839946432005
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004256852	0.2785839946432005
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0041995819999999994	0.2748360359701678
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0041995819999999994	0.2748360359701678
DYSTONIA 28, CHILDHOOD-ONSET	0.0041995819999999994	0.2748360359701678
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0041995819999999994	0.2748360359701678
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0041995819999999994	0.2748360359701678
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0041995819999999994	0.2748360359701678
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0041995819999999994	0.2748360359701678
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0041995819999999994	0.2748360359701678
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0041995819999999994	0.2748360359701678
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0041995819999999994	0.2748360359701678
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0041995819999999994	0.2748360359701678
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0041995819999999994	0.2748360359701678
CAMPTOBRACHYDACTYLY	0.00393701	0.25765236206244113
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00393701	0.25765236206244113
EIKEN SYNDROME	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00393701	0.25765236206244113
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00393701	0.25765236206244113
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00393701	0.25765236206244113
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00393701	0.25765236206244113
JACOBSEN SYNDROME	0.00393701	0.25765236206244113
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00393701	0.25765236206244113
SYMPHALANGISM, DISTAL	0.00393701	0.25765236206244113
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00393701	0.25765236206244113
SCHNECKENBECKEN DYSPLASIA	0.00393701	0.25765236206244113
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00393701	0.25765236206244113
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00393701	0.25765236206244113
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00393701	0.25765236206244113
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00393701	0.25765236206244113
GRANGE SYNDROME; GRNG	0.00393701	0.25765236206244113
Smith-Magenis Syndrome	0.00393701	0.25765236206244113
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00393701	0.25765236206244113
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00393701	0.25765236206244113
METATROPIC DYSPLASIA	0.00393701	0.25765236206244113
FEINGOLD SYNDROME 2; FGLDS2	0.00393701	0.25765236206244113
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00393701	0.25765236206244113
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00393701	0.25765236206244113
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00393701	0.25765236206244113
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00393701	0.25765236206244113
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00393701	0.25765236206244113
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00393701	0.25765236206244113
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00393701	0.25765236206244113
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.00393701	0.25765236206244113
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00393701	0.25765236206244113
BRACHYDACTYLY, TYPE E	0.00393701	0.25765236206244113
WEILL-MARCHESANI SYNDROME 3	0.00393701	0.25765236206244113
PSEUDOACHONDROPLASIA	0.00393701	0.25765236206244113
THANATOPHORIC DYSPLASIA, TYPE II	0.00393701	0.25765236206244113
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00393701	0.25765236206244113
WEYERS ACROFACIAL DYSOSTOSIS	0.00393701	0.25765236206244113
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00393701	0.25765236206244113
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00393701	0.25765236206244113
SYNDACTYLY, TYPE V	0.00393701	0.25765236206244113
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.25765236206244113
PYCNODYSOSTOSIS	0.00393701	0.25765236206244113
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00393701	0.25765236206244113
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00393701	0.25765236206244113
CHITAYAT SYNDROME	0.00393701	0.25765236206244113
ANAUXETIC DYSPLASIA 2; ANXD2	0.00393701	0.25765236206244113
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00393701	0.25765236206244113
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00393701	0.25765236206244113
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00393701	0.25765236206244113
BARDET-BIEDL SYNDROME 4; BBS4	0.00393701	0.25765236206244113
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00393701	0.25765236206244113
HAND-FOOT-GENITAL SYNDROME; HFG	0.00393701	0.25765236206244113
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00393701	0.25765236206244113
CRANIOECTODERMAL DYSPLASIA 3	0.00393701	0.25765236206244113
CLEIDOCRANIAL DYSPLASIA; CCD	0.00393701	0.25765236206244113
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00393701	0.25765236206244113
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00393701	0.25765236206244113
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00393701	0.25765236206244113
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00393701	0.25765236206244113
BRACHYDACTYLY, TYPE E2; BDE2	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00393701	0.25765236206244113
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00393701	0.25765236206244113
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.00393701	0.25765236206244113
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00393701	0.25765236206244113
2q37 monosomy	0.00393701	0.25765236206244113
SATOYOSHI SYNDROME	0.00393701	0.25765236206244113
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00393701	0.25765236206244113
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00393701	0.25765236206244113
SPONDYLOPERIPHERAL DYSPLASIA	0.00393701	0.25765236206244113
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00393701	0.25765236206244113
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.00393701	0.25765236206244113
BARDET-BIEDL SYNDROME 5; BBS5	0.00393701	0.25765236206244113
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00393701	0.25765236206244113
HYPOCHONDROPLASIA	0.00393701	0.25765236206244113
CORNEODERMATOOSSEOUS SYNDROME	0.00393701	0.25765236206244113
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00393701	0.25765236206244113
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00393701	0.25765236206244113
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00393701	0.25765236206244113
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00393701	0.25765236206244113
ADAMS-OLIVER SYNDROME 6; AOS6	0.00393701	0.25765236206244113
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00393701	0.25765236206244113
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00393701	0.25765236206244113
RHYNS SYNDROME; RHYNS	0.00393701	0.25765236206244113
OROFACIODIGITAL SYNDROME IV; OFD4	0.00393701	0.25765236206244113
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00393701	0.25765236206244113
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00393701	0.25765236206244113
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00393701	0.25765236206244113
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00393701	0.25765236206244113
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00393701	0.25765236206244113
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00393701	0.25765236206244113
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00393701	0.25765236206244113
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00393701	0.25765236206244113
BRACHYDACTYLY, LONG-THUMB TYPE	0.00393701	0.25765236206244113
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00393701	0.25765236206244113
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00393701	0.25765236206244113
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00393701	0.25765236206244113
BARDET-BIEDL SYNDROME 18; BBS18	0.00393701	0.25765236206244113
ERYTHEMA OF ACRAL REGIONS	0.003861	0.2526779891143495
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.003861	0.2526779891143495
MEIER-GORLIN SYNDROME 1; MGORS1	0.003861	0.2526779891143495
NAIL-PATELLA SYNDROME	0.003861	0.2526779891143495
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.003861	0.2526779891143495
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.003861	0.2526779891143495
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.003861	0.2526779891143495
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.003861	0.2526779891143495
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.003861	0.2526779891143495
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.003861	0.2526779891143495
LARYNGEAL ABDUCTOR PARALYSIS	0.003861	0.2526779891143495
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.003861	0.2526779891143495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.003861	0.2526779891143495
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.003861	0.2526779891143495
NIEVERGELT SYNDROME	0.003861	0.2526779891143495
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.003861	0.2526779891143495
#150250 LARSEN SYNDROME; LRS	0.003861	0.2526779891143495
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.003861	0.2526779891143495
MECKEL SYNDROME, TYPE 6; MKS6	0.003861	0.2526779891143495
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.003861	0.2526779891143495
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.003861	0.2526779891143495
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.003861	0.2526779891143495
HYPERTELORISM AND TETRALOGY OF FALLOT	0.003861	0.2526779891143495
Rothmund-Thomson syndrome	0.003861	0.2526779891143495
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.003861	0.2526779891143495
POPLITEAL PTERYGIUM SYNDROME	0.003861	0.2526779891143495
BRUCK SYNDROME 2	0.003861	0.2526779891143495
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.003861	0.2526779891143495
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.003861	0.2526779891143495
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.003861	0.2526779891143495
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.003861	0.2526779891143495
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.003861	0.2526779891143495
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.003861	0.2526779891143495
DYSTONIA, DOPA-RESPONSIVE; DRD	0.003861	0.2526779891143495
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.003861	0.2526779891143495
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.003861	0.2526779891143495
#613618 CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	0.003861	0.2526779891143495
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.003861	0.2526779891143495
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.003861	0.2526779891143495
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.003861	0.2526779891143495
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.003861	0.2526779891143495
CAMPOMELIC DYSPLASIA	0.003861	0.2526779891143495
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.003861	0.2526779891143495
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.003861	0.2526779891143495
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.003861	0.2526779891143495
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.003861	0.2526779891143495
KYPHOMELIC DYSPLASIA	0.003861	0.2526779891143495
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.003861	0.2526779891143495
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.003861	0.2526779891143495
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.003861	0.2526779891143495
#259450 BRUCK SYNDROME 1; BRKS1	0.003861	0.2526779891143495
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.003861	0.2526779891143495
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.003861	0.2526779891143495
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.003861	0.2526779891143495
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.003861	0.2526779891143495
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.003861	0.2526779891143495
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.003861	0.2526779891143495
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.003861	0.2526779891143495
ELLIS-VAN CREVELD SYNDROME	0.003861	0.2526779891143495
MASA SYNDROME	0.003861	0.2526779891143495
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.003861	0.2526779891143495
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.003861	0.2526779891143495
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.003861	0.2526779891143495
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.003861	0.2526779891143495
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.003861	0.2526779891143495
PSEUDODIASTROPHIC DYSPLASIA	0.003861	0.2526779891143495
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.003861	0.2526779891143495
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.003861	0.2526779891143495
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.003861	0.2526779891143495
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.003861	0.2526779891143495
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.003861	0.2526779891143495
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.003861	0.2526779891143495
#119800 CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/ORMIRROR-IMAGE POLYDACTYLY; CCF	0.003861	0.2526779891143495
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.003861	0.2526779891143495
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003861	0.2526779891143495
#614209 MECKEL SYNDROME, TYPE 9; MKS9	0.003861	0.2526779891143495
LAMBERT SYNDROME	0.003861	0.2526779891143495
HAMAMY SYNDROME; HMMS	0.00363636	0.237976724293151
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00363636	0.237976724293151
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00363636	0.237976724293151
DUBOWITZ SYNDROME	0.00363636	0.237976724293151
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00363636	0.237976724293151
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00363636	0.237976724293151
FEINGOLD SYNDROME 1; FGLDS1	0.00363636	0.237976724293151
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00363636	0.237976724293151
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00363636	0.237976724293151
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00363636	0.237976724293151
DEAFNESS, X-LINKED 7; DFNX7	0.00363636	0.237976724293151
ZECHI-CEIDE SYNDROME	0.00363636	0.237976724293151
FACIOCARDIORENAL SYNDROME	0.00363636	0.237976724293151
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00363636	0.237976724293151
MICROPHTHALMIA, SYNDROMIC 12	0.00363636	0.237976724293151
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00363636	0.237976724293151
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00363636	0.237976724293151
FRONTONASAL DYSPLASIA 2; FND2	0.00363636	0.237976724293151
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.00363636	0.237976724293151
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.00363636	0.237976724293151
BOOMERANG DYSPLASIA	0.00363636	0.237976724293151
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00363636	0.237976724293151
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00363636	0.237976724293151
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00363636	0.237976724293151
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00363636	0.237976724293151
DIAMOND-BLACKFAN ANEMIA 8	0.00363636	0.237976724293151
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00363636	0.237976724293151
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00363636	0.237976724293151
DEAFNESS-CRANIOFACIAL SYNDROME	0.00363636	0.237976724293151
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00363636	0.237976724293151
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00363636	0.237976724293151
SHORT SYNDROME	0.00363636	0.237976724293151
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00363636	0.237976724293151
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00363636	0.237976724293151
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00363636	0.237976724293151
BEEMER LETHAL MALFORMATION SYNDROME	0.00363636	0.237976724293151
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00363636	0.237976724293151
SCLEROSTEOSIS 1; SOST1	0.00363636	0.237976724293151
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00363636	0.237976724293151
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00363636	0.237976724293151
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00363636	0.237976724293151
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00363636	0.237976724293151
OROFACIODIGITAL SYNDROME XV; OFD15	0.00363636	0.237976724293151
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00363636	0.237976724293151
MECKEL SYNDROME 12; MKS12	0.00363636	0.237976724293151
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00363636	0.237976724293151
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00341297	0.22335726405273282
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00341297	0.22335726405273282
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00341297	0.22335726405273282
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00341297	0.22335726405273282
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00341297	0.22335726405273282
NOONAN SYNDROME 10; NS10	0.00341297	0.22335726405273282
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00341297	0.22335726405273282
TREACHER COLLINS SYNDROME 2; TCS2	0.00341297	0.22335726405273282
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00341297	0.22335726405273282
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00341297	0.22335726405273282
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00341297	0.22335726405273282
2p15-16.1 microdeletion syndrome	0.00341297	0.22335726405273282
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00341297	0.22335726405273282
NOONAN SYNDROME 4; NS4	0.00341297	0.22335726405273282
NOONAN SYNDROME 8; NS8	0.00341297	0.22335726405273282
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00341297	0.22335726405273282
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00341297	0.22335726405273282
MARFAN SYNDROME; MFS	0.00341297	0.22335726405273282
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00341297	0.22335726405273282
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00341297	0.22335726405273282
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00341297	0.22335726405273282
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00341297	0.22335726405273282
ACRORENAL-MANDIBULAR SYNDROME	0.00341297	0.22335726405273282
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00341297	0.22335726405273282
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00341297	0.22335726405273282
Diamond-Blackfan anemia 1	0.00341297	0.22335726405273282
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00341297	0.22335726405273282
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00341297	0.22335726405273282
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00341297	0.22335726405273282
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00341297	0.22335726405273282
RUVALCABA SYNDROME	0.00341297	0.22335726405273282
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00341297	0.22335726405273282
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00341297	0.22335726405273282
#611554 LEOPARD SYNDROME 2	0.00341297	0.22335726405273282
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00341297	0.22335726405273282
Cat-Eye Syndrome (Type I)	0.00341297	0.22335726405273282
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00341297	0.22335726405273282
LEGIUS SYNDROME	0.00341297	0.22335726405273282
MEESTER-LOEYS SYNDROME; MRLS	0.00341297	0.22335726405273282
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00341297	0.22335726405273282
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00341297	0.22335726405273282
PRIMROSE SYNDROME; PRIMS	0.00341297	0.22335726405273282
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00341297	0.22335726405273282
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00341297	0.22335726405273282
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00341297	0.22335726405273282
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00341297	0.22335726405273282
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00341297	0.22335726405273282
TREACHER COLLINS SYNDROME 3; TCS3	0.00341297	0.22335726405273282
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00341297	0.22335726405273282
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00341297	0.22335726405273282
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00341297	0.22335726405273282
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00341297	0.22335726405273282
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00341297	0.22335726405273282
MESOMELIA-SYNOSTOSES SYNDROME	0.00341297	0.22335726405273282
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00341297	0.22335726405273282
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00341297	0.22335726405273282
GILLESPIE SYNDROME; GLSP	0.0033556999999999997	0.21960930537970022
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.0033556999999999997	0.21960930537970022
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0033556999999999997	0.21960930537970022
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.0033556999999999997	0.21960930537970022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0033556999999999997	0.21960930537970022
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0033556999999999997	0.21960930537970022
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0033556999999999997	0.21960930537970022
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0033556999999999997	0.21960930537970022
Mulchandani-Bhoj-Conlin syndrome	0.0033556999999999997	0.21960930537970022
BETHLEM MYOPATHY 1	0.0033556999999999997	0.21960930537970022
SPINOCEREBELLAR ATAXIA 44; SCA44	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0033556999999999997	0.21960930537970022
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.0033556999999999997	0.21960930537970022
%614990 USHER SYNDROME, TYPE IK; USH1K	0.0033556999999999997	0.21960930537970022
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.0033556999999999997	0.21960930537970022
TEMPLE SYNDROME	0.0033556999999999997	0.21960930537970022
NEMALINE MYOPATHY 4	0.0033556999999999997	0.21960930537970022
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0033556999999999997	0.21960930537970022
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0033556999999999997	0.21960930537970022
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0033556999999999997	0.21960930537970022
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0033556999999999997	0.21960930537970022
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.0033556999999999997	0.21960930537970022
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0033556999999999997	0.21960930537970022
#613723 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	0.0033556999999999997	0.21960930537970022
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0033556999999999997	0.21960930537970022
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0033556999999999997	0.21960930537970022
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0033556999999999997	0.21960930537970022
CARDIAC-UROGENITAL SYNDROME; CUGS	0.0033556999999999997	0.21960930537970022
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0033556999999999997	0.21960930537970022
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.0033556999999999997	0.21960930537970022
#613158 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED	0.0033556999999999997	0.21960930537970022
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.0033556999999999997	0.21960930537970022
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.0033556999999999997	0.21960930537970022
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.0033556999999999997	0.21960930537970022
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0033556999999999997	0.21960930537970022
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0033556999999999997	0.21960930537970022
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.0033556999999999997	0.21960930537970022
#610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	0.0033556999999999997	0.21960930537970022
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.0033556999999999997	0.21960930537970022
GLYCOGEN STORAGE DISEASE IXC	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.0033556999999999997	0.21960930537970022
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0033556999999999997	0.21960930537970022
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0033556999999999997	0.21960930537970022
USHER SYNDROME, TYPE IF	0.0033556999999999997	0.21960930537970022
LESCH-NYHAN SYNDROME; LNS	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, X-LINKED 97; MRX97	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0033556999999999997	0.21960930537970022
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0033556999999999997	0.21960930537970022
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0033556999999999997	0.21960930537970022
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.0033556999999999997	0.21960930537970022
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0033556999999999997	0.21960930537970022
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0033556999999999997	0.21960930537970022
GLYCOGEN STORAGE DISEASE IXA	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.0033556999999999997	0.21960930537970022
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.0033556999999999997	0.21960930537970022
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.0033556999999999997	0.21960930537970022
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, X-LINKED 19	0.0033556999999999997	0.21960930537970022
NEMALINE MYOPATHY 2; NEM2	0.0033556999999999997	0.21960930537970022
SALIH MYOPATHY; SALMY	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.0033556999999999997	0.21960930537970022
SENGERS SYNDROME	0.0033556999999999997	0.21960930537970022
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.0033556999999999997	0.21960930537970022
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.0033556999999999997	0.21960930537970022
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.0033556999999999997	0.21960930537970022
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0033556999999999997	0.21960930537970022
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0033556999999999997	0.21960930537970022
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0033556999999999997	0.21960930537970022
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.0033556999999999997	0.21960930537970022
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.0033556999999999997	0.21960930537970022
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0033556999999999997	0.21960930537970022
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0033556999999999997	0.21960930537970022
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0033556999999999997	0.21960930537970022
MEIER-GORLIN SYNDROME 5; MGORS5	0.0033556999999999997	0.21960930537970022
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0033556999999999997	0.21960930537970022
BRUNNER SYNDROME; BRNRS	0.0033556999999999997	0.21960930537970022
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0033556999999999997	0.21960930537970022
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0033556999999999997	0.21960930537970022
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0033556999999999997	0.21960930537970022
260150 PALANT CLEFT PALATE SYNDROME	0.0033556999999999997	0.21960930537970022
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.0033556999999999997	0.21960930537970022
MYOPATHY, CENTRONUCLEAR, 5	0.0033556999999999997	0.21960930537970022
#615731 NEMALINE MYOPATHY 9; NEM9	0.0033556999999999997	0.21960930537970022
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.0033556999999999997	0.21960930537970022
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.0033556999999999997	0.21960930537970022
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.0033556999999999997	0.21960930537970022
NEMALINE MYOPATHY 1; NEM1	0.0033556999999999997	0.21960930537970022
#614869 USHER SYNDROME, TYPE IJ; USH1J	0.0033556999999999997	0.21960930537970022
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.0033556999999999997	0.21960930537970022
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0033556999999999997	0.21960930537970022
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0033556999999999997	0.21960930537970022
NEMALINE MYOPATHY 3; NEM3	0.0033556999999999997	0.21960930537970022
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0033556999999999997	0.21960930537970022
#613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL	0.0033556999999999997	0.21960930537970022
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0033556999999999997	0.21960930537970022
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.0033556999999999997	0.21960930537970022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0033556999999999997	0.21960930537970022
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0033556999999999997	0.21960930537970022
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0033556999999999997	0.21960930537970022
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0033556999999999997	0.21960930537970022
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.0033556999999999997	0.21960930537970022
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0033556999999999997	0.21960930537970022
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0033556999999999997	0.21960930537970022
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.0033556999999999997	0.21960930537970022
SPINOCEREBELLAR ATAXIA 13	0.0033556999999999997	0.21960930537970022
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.11515683191381772
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11515683191381772
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.11515683191381772
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.11515683191381772
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.11515683191381772
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.11515683191381772
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.11515683191381772
LISSENCEPHALY 4	0.001759633	0.11515683191381772
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.11515683191381772
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.11515683191381772
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.11515683191381772
PROPIONIC ACIDEMIA	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.11515683191381772
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.11515683191381772
Pierpont syndrome	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001759633	0.11515683191381772
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.11515683191381772
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.11515683191381772
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.11515683191381772
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.11515683191381772
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.11515683191381772
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001759633	0.11515683191381772
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.11515683191381772
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.11515683191381772
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.11515683191381772
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.11515683191381772
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.11515683191381772
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.11515683191381772
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.11515683191381772
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.11515683191381772
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.11515683191381772
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.11515683191381772
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.11515683191381772
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.11515683191381772
COFFIN-SIRIS SYNDROME 3; CSS3	0.001759633	0.11515683191381772
COACH SYNDROME	0.001759633	0.11515683191381772
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001759633	0.11515683191381772
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.11515683191381772
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.11515683191381772
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.11515683191381772
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11515683191381772
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.11515683191381772
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.11515683191381772
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.11515683191381772
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.11515683191381772
COFFIN-SIRIS SYNDROME 4; CSS4	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11515683191381772
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.11515683191381772
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.11515683191381772
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.11515683191381772
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11515683191381772
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.11515683191381772
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.11515683191381772
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.11515683191381772
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.001759633	0.11515683191381772
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.11515683191381772
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.11515683191381772
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001759633	0.11515683191381772
LEIGH SYNDROME; LS	0.001759633	0.11515683191381772
GAUCHER DISEASE, TYPE II	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001759633	0.11515683191381772
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.11515683191381772
XQ25 DUPLICATION SYNDROME	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.001759633	0.11515683191381772
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.11515683191381772
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.11515683191381772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.11515683191381772
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.11515683191381772
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.11515683191381772
TIMOTHY SYNDROME; TS	0.001759633	0.11515683191381772
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.11515683191381772
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.11515683191381772
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.11515683191381772
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001759633	0.11515683191381772
WAISMAN SYNDROME; WSMN	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001759633	0.11515683191381772
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.11515683191381772
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001759633	0.11515683191381772
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.11515683191381772
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.11515683191381772
SULFOCYSTEINURIA	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11515683191381772
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11515683191381772
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.11515683191381772
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.11515683191381772
PETTIGREW SYNDROME	0.001759633	0.11515683191381772
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.11515683191381772
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.11515683191381772
PALLISTER-HALL SYNDROME	0.001759633	0.11515683191381772
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.11515683191381772
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001759633	0.11515683191381772
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.11515683191381772
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.11515683191381772
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.11515683191381772
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001759633	0.11515683191381772
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001759633	0.11515683191381772
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11515683191381772
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.11515683191381772
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.11515683191381772
PHACE ASSOCIATION	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.11515683191381772
SALLA DISEASE	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.11515683191381772
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001759633	0.11515683191381772
EMANUEL SYNDROME	0.001759633	0.11515683191381772
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.11515683191381772
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.11515683191381772
HARTNUP DISORDER	0.001759633	0.11515683191381772
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11515683191381772
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001759633	0.11515683191381772
BAND HETEROTOPIA; BH	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.11515683191381772
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.11515683191381772
Cerebral creatine deficiency syndrome 2	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.11515683191381772
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11515683191381772
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.11515683191381772
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.11515683191381772
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.11515683191381772
SCHINDLER DISEASE, TYPE I	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001759633	0.11515683191381772
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.11515683191381772
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.11515683191381772
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.11515683191381772
KAGAMI-OGATA SYNDROME	0.001759633	0.11515683191381772
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.11515683191381772
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.11515683191381772
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11515683191381772
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.11515683191381772
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.11515683191381772
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.11515683191381772
ELEJALDE DISEASE	0.001759633	0.11515683191381772
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001759633	0.11515683191381772
KBG SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.11515683191381772
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.11515683191381772
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.11515683191381772
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001759633	0.11515683191381772
KLEEFSTRA SYNDROME 2; KLEFS2	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.11515683191381772
COFFIN-SIRIS SYNDROME 5	0.001759633	0.11515683191381772
Pontine tegmental cap dysplasia	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.11515683191381772
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.11515683191381772
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001759633	0.11515683191381772
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.11515683191381772
ADENYLOSUCCINASE DEFICIENCY	0.001759633	0.11515683191381772
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.11515683191381772
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.11515683191381772
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001759633	0.11515683191381772
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.11515683191381772
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.11515683191381772
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.11515683191381772
MACDERMOT-WINTER SYNDROME	0.001759633	0.11515683191381772
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.11515683191381772
LISSENCEPHALY 1; LIS1	0.001759633	0.11515683191381772
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001759633	0.11515683191381772
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.11515683191381772
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.11515683191381772
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.11515683191381772
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.11515683191381772
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.11515683191381772
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.11515683191381772
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.001759633	0.11515683191381772
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.11515683191381772
CITRULLINEMIA, CLASSIC	0.001759633	0.11515683191381772
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.11515683191381772
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.11515683191381772
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.11515683191381772
AICARDI-GOUTIERES SYNDROME 7	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 7	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.11515683191381772
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.11515683191381772
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.11515683191381772
WEBB-DATTANI SYNDROME; WEDAS	0.001759633	0.11515683191381772
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.11515683191381772
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11515683191381772
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.05993010132335009
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.05993010132335009
THYROCEREBRORETINAL SYNDROME	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.05993010132335009
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.05993010132335009
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.05993010132335009
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.05993010132335009
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.05993010132335009
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.05993010132335009
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.05993010132335009
PAPILLORENAL SYNDROME	0.000915751	0.05993010132335009
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.05993010132335009
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.05993010132335009
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.05993010132335009
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.05993010132335009
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.05993010132335009
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.05993010132335009
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.05993010132335009
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.05993010132335009
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.05993010132335009
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.05993010132335009
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.05993010132335009
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.05993010132335009
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.05993010132335009
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.05993010132335009
STURGE-WEBER SYNDROME	0.000915751	0.05993010132335009
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.05993010132335009
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.05993010132335009
HUNTINGTON DISEASE; HD	0.000915751	0.05993010132335009
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.05993010132335009
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.05993010132335009
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.05993010132335009
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.05993010132335009
GURRIERI SYNDROME	0.000915751	0.05993010132335009
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.05993010132335009
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 47	0.000915751	0.05993010132335009
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.05993010132335009
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.05993010132335009
THREONINEMIA	0.000915751	0.05993010132335009
SNEDDON SYNDROME	0.000915751	0.05993010132335009
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.05993010132335009
EPILEPSY-TELANGIECTASIA	0.000915751	0.05993010132335009
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.05993010132335009
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.05993010132335009
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.05993010132335009
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.05993010132335009
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.05993010132335009
KEUTEL SYNDROME; KTLS	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.05993010132335009
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.05993010132335009
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.05993010132335009
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.05993010132335009
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.05993010132335009
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.05993010132335009
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.05993010132335009
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.05993010132335009
Fabry disease	0.000915751	0.05993010132335009
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.05993010132335009
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.05993010132335009
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.05993010132335009
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.05993010132335009
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.05993010132335009
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.05993010132335009
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.05993010132335009
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.05993010132335009
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.05993010132335009
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.05993010132335009
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.05993010132335009
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.05993010132335009
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.05993010132335009
DIAMINOPENTANURIA	0.000915751	0.05993010132335009
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.05993010132335009
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.05993010132335009
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.05993010132335009
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.05993010132335009
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.05993010132335009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.05993010132335009
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.05993010132335009
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.05993010132335009
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.05993010132335009
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.05993010132335009
HYPERPROLINEMIA, TYPE II	0.000915751	0.05993010132335009
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.05993010132335009
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.05993010132335009
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.05993010132335009
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.05993010132335009
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.05993010132335009
Wolf-Hirschhorn Syndrome	0.000915751	0.05993010132335009
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.05993010132335009
PARIETAL FORAMINA	0.000915751	0.05993010132335009
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.05993010132335009
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.05993010132335009
Adrenoleukodystrophy	0.000915751	0.05993010132335009
HYPER-BETA-ALANINEMIA	0.000915751	0.05993010132335009
PHENYLKETONURIA	0.000915751	0.05993010132335009
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.05993010132335009
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.05993010132335009
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.05993010132335009
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.05993010132335009
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.05993010132335009
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.05993010132335009
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.05993010132335009
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.05993010132335009
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.05993010132335009
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.05993010132335009
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.05993010132335009
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000915751	0.05993010132335009
KIFAFA SEIZURE DISORDER	0.000915751	0.05993010132335009
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.05993010132335009
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.05993010132335009
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.05993010132335009
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.05993010132335009
HHHH SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.05993010132335009
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.05993010132335009
KAPUR-TORIELLO SYNDROME	0.000915751	0.05993010132335009
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.05993010132335009
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.05993010132335009
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.05993010132335009
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.05993010132335009
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.05993010132335009
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.05993010132335009
GITELMAN SYNDROME	0.000915751	0.05993010132335009
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.05993010132335009
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.05993010132335009
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.05993010132335009
CROUZON SYNDROME	0.000915751	0.05993010132335009
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.05993010132335009
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.05993010132335009
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.05993010132335009
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.05993010132335009
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.05993010132335009
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.05993010132335009
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.05993010132335009
CROME SYNDROME	0.000915751	0.05993010132335009
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.05993010132335009
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.05993010132335009
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.05993010132335009
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.05993010132335009
COWDEN SYNDROME 5; CWS5	0.000915751	0.05993010132335009
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.05993010132335009
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.05993010132335009
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.05993010132335009
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.05993010132335009
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.05993010132335009
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
FOUNTAIN SYNDROME	0.000915751	0.05993010132335009
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.05993010132335009
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.05993010132335009
DYSOSTEOSCLEROSIS	0.000915751	0.05993010132335009
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.05993010132335009
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.05993010132335009
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.05993010132335009
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.05993010132335009
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.05993010132335009
TAY-SACHS DISEASE; TSD	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY	0.000915751	0.05993010132335009
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.05993010132335009
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.05993010132335009
ALEXANDER DISEASE	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.05993010132335009
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.05993010132335009
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.05993010132335009
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.05993010132335009
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.05993010132335009
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.05993010132335009
FLYNN-AIRD SYNDROME	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.05993010132335009
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.05993010132335009
PSEUDO-TORCH SYNDROME 2	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.05993010132335009
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.05993010132335009
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.05993010132335009
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.05993010132335009
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.05993010132335009
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.05993010132335009
SECKEL SYNDROME 7; SCKL7	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.05993010132335009
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.05993010132335009
1p36 microdeletion syndrome	0.000915751	0.05993010132335009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.05993010132335009
PERRAULT SYNDROME 3	0.000915751	0.05993010132335009
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.05993010132335009
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.05993010132335009
LOWE OCULOCEREBRORENAL SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.05993010132335009
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.05993010132335009
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.05993010132335009
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.05993010132335009
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.05993010132335009
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.05993010132335009
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.05993010132335009
ASPARTYLGLUCOSAMINURIA; AGU	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.05993010132335009
DARIER-WHITE DISEASE; DAR	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.05993010132335009
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.05993010132335009
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.05993010132335009
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.05993010132335009
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.05993010132335009
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.05993010132335009
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.05993010132335009
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.05993010132335009
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.05993010132335009
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.05993010132335009
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.05993010132335009
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000915751	0.05993010132335009
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.05993010132335009
HYPERLYSINEMIA, TYPE I	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.05993010132335009
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.05993010132335009
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.05993010132335009
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
RAMON SYNDROME	0.000915751	0.05993010132335009
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.05993010132335009
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.05993010132335009
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.05993010132335009
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.05993010132335009
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.05993010132335009
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.05993010132335009
INCONTINENTIA PIGMENTI; IP	0.000915751	0.05993010132335009
LISSENCEPHALY 5; LIS5	0.000915751	0.05993010132335009
COWDEN SYNDROME 6; CWS6	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.05993010132335009
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.05993010132335009
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.05993010132335009
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.05993010132335009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.05993010132335009
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.05522673059046762
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.05522673059046762
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.05522673059046762
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 25	0.000843882	0.05522673059046762
SENIOR-LOKEN SYNDROME 9	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.05522673059046762
SEPTOOPTIC DYSPLASIA	0.000843882	0.05522673059046762
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.05522673059046762
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.05522673059046762
SECKEL SYNDROME 8; SCKL8	0.000843882	0.05522673059046762
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.05522673059046762
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.05522673059046762
JOUBERT SYNDROME 15	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.05522673059046762
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.05522673059046762
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.05522673059046762
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.05522673059046762
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.05522673059046762
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.05522673059046762
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.05522673059046762
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.05522673059046762
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.05522673059046762
JOUBERT SYNDROME 7	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.05522673059046762
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.05522673059046762
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.05522673059046762
CHAR SYNDROME	0.000843882	0.05522673059046762
REVESZ SYNDROME	0.000843882	0.05522673059046762
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.05522673059046762
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.05522673059046762
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.05522673059046762
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.05522673059046762
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.05522673059046762
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.05522673059046762
MECKEL SYNDROME 13; MKS13	0.000843882	0.05522673059046762
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.05522673059046762
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.05522673059046762
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.05522673059046762
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.05522673059046762
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.05522673059046762
HYDROXYKYNURENINURIA	0.000843882	0.05522673059046762
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.05522673059046762
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.05522673059046762
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.05522673059046762
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.05522673059046762
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.05522673059046762
OPTIC ATROPHY 11; OPA11	0.000843882	0.05522673059046762
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.05522673059046762
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.05522673059046762
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000843882	0.05522673059046762
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.05522673059046762
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.05522673059046762
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000843882	0.05522673059046762
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.05522673059046762
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.05522673059046762
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.05522673059046762
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.05522673059046762
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.05522673059046762
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.05522673059046762
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.05522673059046762
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.05522673059046762
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.05522673059046762
NETHERTON SYNDROME; NETH	0.000843882	0.05522673059046762
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.05522673059046762
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.05522673059046762
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.05522673059046762
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.05522673059046762
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.05522673059046762
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.05522673059046762
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.05522673059046762
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.05522673059046762
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.05522673059046762
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.05522673059046762
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.05522673059046762
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.05522673059046762
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.05522673059046762
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.05522673059046762
Leukotriene C4 synthase deficiency	0.000843882	0.05522673059046762
Cerebral creatine deficiency syndrome 3	0.000843882	0.05522673059046762
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.05522673059046762
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.05522673059046762
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.05522673059046762
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.05522673059046762
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.05522673059046762
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.05522673059046762
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.05522673059046762
SILVER-RUSSELL SYNDROME; SRS	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.05522673059046762
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.05522673059046762
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.05522673059046762
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.05522673059046762
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.05522673059046762
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.05522673059046762
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.05522673059046762
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.05522673059046762
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.05522673059046762
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.05522673059046762
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.05522673059046762
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.05522673059046762
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.05522673059046762
Jawad syndrome	0.000843882	0.05522673059046762
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.05522673059046762
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.05522673059046762
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.05522673059046762
WAARDENBURG-SHAH SYNDROME	0.000843882	0.05522673059046762
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.05522673059046762
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.05522673059046762
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.05522673059046762
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.05522673059046762
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.05522673059046762
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.05522673059046762
JOUBERT SYNDROME 26	0.000843882	0.05522673059046762
CDAGS SYNDROME	0.000843882	0.05522673059046762
HOLOPROSENCEPHALY 11	0.000843882	0.05522673059046762
AUSTRALIA ANTIGEN	0.000843882	0.05522673059046762
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.05522673059046762
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.05522673059046762
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.05522673059046762
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.05522673059046762
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.05522673059046762
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.05522673059046762
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.05522673059046762
NAVAJO NEUROHEPATOPATHY	0.000843882	0.05522673059046762
MEIER-GORLIN SYNDROME 7	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.05522673059046762
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.05522673059046762
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.05522673059046762
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.05522673059046762
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000843882	0.05522673059046762
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.05522673059046762
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.05522673059046762
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.05522673059046762
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.05522673059046762
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.05522673059046762
ARIMA SYNDROME	0.000843882	0.05522673059046762
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.05522673059046762
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.05522673059046762
MUCOLIPIDOSIS IV; ML4	0.000843882	0.05522673059046762
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.05522673059046762
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.05522673059046762
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.05522673059046762
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.05522673059046762
JOUBERT SYNDROME 6	0.000843882	0.05522673059046762
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.05522673059046762
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000843882	0.05522673059046762
300270 ADRENOMYODYSTROPHY	0.000843882	0.05522673059046762
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.05522673059046762
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.05522673059046762
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.05522673059046762
JOUBERT SYNDROME 21	0.000843882	0.05522673059046762
JOUBERT SYNDROME 8	0.000843882	0.05522673059046762
CURRY-JONES SYNDROME	0.000843882	0.05522673059046762
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.05522673059046762
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.05522673059046762
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.05522673059046762
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.05522673059046762
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.05522673059046762
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.05522673059046762
CULLER-JONES SYNDROME; CJS	0.000843882	0.05522673059046762
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.05522673059046762
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.05522673059046762
TYSHCHENKO SYNDROME	0.000843882	0.05522673059046762
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.05522673059046762
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.05522673059046762
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.05522673059046762
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.05522673059046762
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.05522673059046762
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.05522673059046762
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.05522673059046762
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.05522673059046762
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.05522673059046762
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.05522673059046762
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.05522673059046762
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.05522673059046762
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000843882	0.05522673059046762
EVEN-PLUS SYNDROME	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.05522673059046762
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.05522673059046762
PELLAGRA-LIKE SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 2	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.05522673059046762
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.05522673059046762
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.05522673059046762
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.05522673059046762
CURRARINO SYNDROME	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.05522673059046762
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.05522673059046762
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.05522673059046762
JOUBERT SYNDROME 28	0.000843882	0.05522673059046762
LOWRY-MACLEAN SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 27	0.000843882	0.05522673059046762
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.05522673059046762
ALSTROM SYNDROME; ALMS	0.000843882	0.05522673059046762
LIG4 SYNDROME	0.000843882	0.05522673059046762
OROTIC ACIDURIA	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.05522673059046762
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.05522673059046762
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.05522673059046762
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.05522673059046762
Mental retardation, autosomal dominant 21	0.000843882	0.05522673059046762
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.05522673059046762
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.05522673059046762
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.05522673059046762
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.05522673059046762
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.05522673059046762
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.05522673059046762
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.05522673059046762
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.05522673059046762
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.05522673059046762
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.05522673059046762
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.05522673059046762
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.05522673059046762
Bardet-Biedl syndrome 2	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.05522673059046762
#170100 PROLIDASE DEFICIENCY	0.000843882	0.05522673059046762
